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ABSTRACT  
 
AIM 
To compare the Cytotoxicity, Alkaline phosphatase activity and Genetic expression of 
Mineralization between “White Portland Cement mixed with Radiopacifying agents 
(Iodoform/Zirconium dioxide/Bismuth oxide)” and “MTA” in Mouse MC3T3-E1 
Osteoblast cells. 
Materials & Methods 
WPC was mixed with three different radiopacifying agents in the ratio of 4:1 by 
weight and divided into three groups. Along with MTA and control group, totally 5 
groups were taken at a concentration of 0.02 mg/ml and compared the cytotoxicity by 
MTT assay and Alkaline phosphatase activity by Lowry method. Then qRT-PCR 
analysis was performed to detect the genetic expression of Mineralization and 
cytokines. LPS at a conc. of 10 μg/ml was added to the experimental materials and 
qRT-PCR analysis was again performed to detect the expression levels of cytokines 
despite LPS stimulation. The values were analyzed statistically by One Way Analysis 
of Variance followed by multiple comparison Tukey HSD test. 
Results 
The Cell survival ability was decreased in the 1st and 2nd day but significantly 
increased on the 3rd day for all the experimental groups. The Alkaline phosphatase 
activity was decreased on the 3rd day but increased gradually from 3rd day to 15th day 
for all the experimental groups. The gene expression of all Mineralization associated 
proteins were decreased on the 1st and 2nd day but significantly increased on the 3rd 
day for all the experimental groups. With and without LPS stimulation, the cytokines, 
TNF α was detected at low levels, IL -6 was maintained and IL-1 α was highly 
suppressed for all the experimental groups. All the results were statistically 
insignificant among the experimental groups. 
Conclusion 
Hence it was concluded that Portland cement can be used in place of MTA after 
addition of any Radiopacifiers like Bismuth oxide, Iodoform and Zirconium dioxide. 
Key words: Cytotoxicity, Gene Expression, MTA, Portland Cement. 
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Pulpal diseases may progress to periapical lesions. The incidence of cysts & 
granulomas within periapical lesions are 55% & 70.07% respectively6. It is accepted 
that all inflammatory periapical lesions should be initially treated with conservative 
nonsurgical endodontic procedures. But in some cases, treatment failure is solved by 
endodontic surgery. Periapical surgery usually consists of apicocectomy, apical cavity 
preparation and root end filling to seal the communication pathways between the root 
canal system and periapical tissues.   
 
 For a long time, the root end filling materials of choice have been Amalgam, 
IRM, Super-EBA and Glass ionomer cements, Composites, Zinc phosphate, Poly 
HEMA, Biobond and EDH adhesive, Bone cements, Compomer, Hydroxyapatite 
cements, Resorcine-formalin resin, etc. However, these materials have the 
disadvantages of undergoing corrosion, electrolysis, delayed expansion and staining 
(amalgam), marginal leakage, moisture sensitivity and toxicity for vital tissues41. 
 
 MTA (Pro Root MTA, Dentsply Tulsa, U.S.A.) basically composed of 
Portland cement 75% by weight, gypsum 5% by weight and bismuth oxide 20% by 
weight.  The major component Portland cement is a mixture of dicalcium silicate, 
tricalcium silicate and tricalcium aluminate. Bismuth oxide is added to provide 
radiopacity greater than dentin. 
 
 MTA exhibits acceptable in vivo biologic performance when used for root-end 
fillings, perforation repairs, pulp capping, pulpotomy, and apexification treatment. 
MTA induces biomineralization of cementoblasts & osteoblasts and stimulate 
mineralization.  
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 Portland cement is the most common type of cement in general use around the 
world. Type I Portland cement is the main component of MTA with addition of 20 
wt% bismuth oxide at 4:1 ratio to provide radiopacity. Comparative chemical study 
and X-ray diffraction analysis of MTA and Portland cements proved that Portland 
cement is similar to MTA with the exception of Bismuth oxide which is present only 
in MTA33, 25. Histologic evaluation studies showed that Portland cement showed 
similar inflammatory results when compared with MTA. Portland cement also proved 
to be comparable with MTA in hard tissue formation when used as direct pulp 
capping material by maintaining pulp vitality25, 4, and 55.  Portland cement does not have 
sufficient radiopacity to be visualised radiographically and thus a radiopacifying agent 
must be added to its composition. Bismuth oxide 20% is the radiopacifier present in 
MTA, atleast 15% of bismuth oxide is to be added to white Portland cement to 
provide sufficient radiopacity. However, it is questioned if bismuth oxide would be 
the best radiopacifying agent to be associated with Portland cement. Coomaraswamy 
et al (2007)14   reported that the addition of bismuth oxide as a radiopacifier decreases 
mechanical stability by introducing flaws and increased porosity. Hence there is a 
need to search for an alternative radiopacifying agent to be associated with Portland 
cement.  
 
 The ISO 6876/2001 standard established that root canal sealers should be at 
least as radiopaque as 3mmAl. According to the American National Standards 
Institute and American Dental Association Specification No.57, endodontic filling 
materials should present a difference in radiopacity equivalent to at least 2mmAl in 
comparison to bone or dentin.  Materials like Bismuth carbonate, Iodoform, 
Zirconium dioxide, Barium sulphate and Bismuth subnitrate had radiopacity values 
above that of dentin and the minimum recommended by the ANSI/ADA can be used 
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as radiopacifiers. The possible interference of the radiopacifiers with biocompatibility 
of Portland cement should be investigated. Carlos Alberto et al (2006)12 reported 
that Iodoform 20wt% added with Portland cement showed similar tissue response as 
MTA, in a rat subcutaneous tissue implantation study.  
 
An ideal root-end filling material should be biocompatible with normal 
tissues. Assessment of biocompatibility in vitro using cell culture techniques has been 
widely used. Cell types used varied from immortal cell lines to animal cells and 
fibroblasts. Primary osteoblasts have however been shown to be more appropriate for 
testing endodontic materials in cell culture as they are more sensitive and form 
mineralized nodules when exposed to differentiation media43. Enzyme assay measures 
the metabolic activity of cells grown over the materials under study. This can be done 
by using methyltetrazolium (MTT) assay. The MTT assay40 is dependent on the intact 
activity of the mitochondrial enzyme, succinate dehydrogenase, which is impaired 
after exposure of cells to toxic surroundings. 
 
The cellular events following an insult/injury in hard tissue formation 
generally undergo the following sequence; chemotaxis, proliferation, differentiation, 
mineralization of hard tissue matrix and cessation of hard tissue formation activity 47. 
The presence of ALP is indicative of cells in differentiation phase. ALP is a 
hydrolytic enzyme with strong relationship to the process of mineralization and a 
known marker for hard tissue forming cells, osteonectin and osteopontin. To evaluate 
the effect of MTA and Portland cement on activities of osteoblast, expression of BSP, 
OPN, OCN, COL I genes were measured by the method of Quantitative Reverse 
Transcriptase Polymerized Chain Reaction (qRT-PCR) in the presence of those 
materials. This method is a technology to monitor gene expression over time, and it is 
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considered as the gold standard in the field of gene detection because of its sensitivity, 
precise gene quantification, real-time character, and time-saving characteristic in 
comparison to other methods such as Northern blotting, Southern blotting, and  RNase 
protection assays. 
 
MTA materials have demonstrated remarkable success as root-end fillings. 
Therefore it has been suggested that the cellular response to MTA may involve 
modulating inflammation. In 1997 and 1998, Koh et al28, 29, reported that human MG-
63 osteosarcoma cells produced IL-1alpha, IL-1beta, and IL-6 upon exposure to 
MTA. However in 1999, Mitchell et al.35 found that the same cells produced only IL-
6 in response to variant formulations of MTA, without expressing IL-1alpha.  
 
  Hence the aim of this study is to evaluate and compare ‘MTA’ and 
“Portland Cement with three different Radiopacifying agents (Iodoform, Zirconium 
oxide, Bismuth oxide)” by Osteoblast cell survival, Alkaline phosphatase activity and 
Genetic expression of Mineralization. 
 
 
 
 
 
 
  
 
 
 
 
 
 
Aim & Objectives 
Aim and Objectives 
 
5 
 
 
 
 
 The aim of this study was to compare the Cytotoxicity, Alkaline phosphatase 
activity and Genetic expression of Mineralization associated genes and Cytokines of 
White Portland Cement (WPC) (80wt%) mixed with (20wt%) Radiopacifying agents 
(Iodoform/Zirconium dioxide /Bismuth oxide)  with MTA (Pro Root MTA) in Mouse 
MC3T3-E1 Osteoblast cells.  
 
The objectives were: 
 
1. To mix WPC 80wt% with Bismuth oxide 20wt%, WPC 80wt% with Iodoform 
20wt%, and WPC 80wt% with 20wt% Zirconium dioxide.  
 
2. To compare the cytotoxicity of above materials and MTA using MTT assay in 
mouse MC3T3-E1 osteoblast cells.  
 
3. To compare the alkaline phosphates activity of above materials and MTA.  
 
 
4. To compare the genetic expression of mineralization associated proteins of 
above materials and MTA using RT-PCR.  
 
5. To compare the genetic expression of cytokines involved in the mineralization 
of above materials and MTA using RT-PCR with & without in vivo simulated 
inflammatory condition. 
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Mineral Trioxide Aggregate (MTA): 
 
 Mineral Trioxide Aggregate (MTA) was a biomaterial that has been 
investigated for endodontic applications since the early 1990s. Originally developed 
by Torabinejad at Loma Linda university.  MTA was first described in the dental 
scientific literature in 1993 and was given approval for endodontic use by the U.S. 
Food and Drug Administration in 1998.  
 
 Torabinejad et al (1995)38 determined the chemical composition, pH, 
compressive strength and radiopacity of MTA. He showed that the main molecules 
present in MTA are calcium and phosphorus ions. In addition, MTA had a pH of 10.2 
initially which then rised to 12.5 three hours after mixing. MTA was more radiopaque 
than Super EBA and IRM. MTA had a longer setting time of 2 hours and 45 minutes. 
At 24 hours MTA had the lower compressive strength of 40MPa but it increased after 
21 days to 67 MPa.  
 
 Torabinejad et al (1995)37 showed that the tissue reaction to MTA 
implantation in the mandible of guinea pig was milder than that observed with Super 
EBA implantation. It seemed that Super EBA and MTA were biocompatible.  
 
 Torabinejad et al (1995)39  proved that MTA provided better adaptation seal 
than commonly used root end filling materials such as Amalgam, Super EBA and 
IRM.  
 
 Eng Tiong Koh et al (1998)20 proved that the ELISA assays revealed raised 
levels of all interleukins at all periods when cells were grown in the presence of 
MTA; in contrast, cells grown alone or with IRM produced undetectable amounts. 
The macrophage colony stimulating factor was produced by cells irrespective of the 
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group. It seemed that MTA offers a biologically active substrate for bone cells and 
stimulated interleukin production.  
 
 Holland R et al (1999)23 theorized that the tricalcium oxide in MTA reacted 
with tissue fluids to form calcium hydroxide, resulting in hard-tissue formation in a 
manner similar to that of calcium hydroxide. 
 
 Compared with calcium hydroxide, MTA had demonstrated a greater ability to 
maintain the integrity of pulp tissue.  Aeinehchi et al (2003)1 showed that histologic 
evaluation of pulpal tissue in animals and humans demonstrated that MTA produced a 
thicker dentinal bridge, less inflammation, less hyperemia and less pulpal necrosis 
compared with calcium hydroxide.MTA also appeared to induce the formation of a 
dentin bridge at a faster rate than did calcium hydroxide. The process by which MTA 
acted to induce dentin bridge formation, however, is not known. 
 
 In 2002, in addition to the traditional gray MTA (GMTA), White MTA 
(WMTA) was introduced. Saeed Asgary et al (2005)48 concluded that concentrations 
of Al2O3 , MgO, and particularly FeO in WMTA was  considerably lower than those 
found in GMTA. Differences in the observed FeO concentration were thought to be 
primarily responsible for the variation in color of the WMTA in comparison with 
GMTA.  
 
 Sarkar et al (2005)51 showed that MTA materials were a mixture of a refined 
Portland cement and Bismuth oxide as radiopacifier and trace amounts of SiO2, CaO, 
MgO, K2SO4, AND Na2SO4. The major component of  Portland cement was a mixture 
of dicalcium silicate, tricalcium silicate, tricalcium aluminate, gypsum and 
tetracalcium aluminoferrite. 
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 Camilleri (2006)10 concluded that MTA materials formed a colloidal gel that 
solidifies to a hard structure in approximately 3-4 h. Hydrated MTA products had an 
initial pH of 10.2 which rises to 12.5 three hours after mixing. The setting process was 
described as a hydration reaction of tricalcium silicate and dicalcium silicate, similar 
to its parent compound Portland cement that needed sufficient water for reaction to 
occur. 
 
 MTA has a wide clinical application. Peng et al(2006)42  showed that  in 
primary molar teeth with vital pulp exposure caused by caries or trauma, a pulpotomy 
performed with MTA resulted in better clinically and radiographically observed 
outcomes. Fewer undesirable responses were recorded for MTA than when 
formocresol was used. 
 
 Ahmed et al (2008)2  showed that Pro Root MTA has excellent sealing ability 
and could be used with or without matrix in repair of large furcation perforations  and  
the use of IRM to repair large furcation perforations should be limited. 
 
 Witherspoon et al (2008)62 showed that MTA obturation of canals with open 
apices was a viable alternative to the use of Ca (OH) 2 to induce apical closure. 
 
 William Saunders et al (2008)61 in his prospective clinical study of 
periradicular surgery concluded that MTA as a root end filling material showed a high 
success rate of 88.8 %  
MTA and Portland Cement 
 
 Jacob Saidon et al (2003)26  compared the in vitro cytotoxic effect of MTA 
and Portland cement in L929 cells and tissue reactions of both the materials in bone 
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implantation in the mandibles of guinea pigs. There was no difference in cell reactions 
in vitro. Bone healing and minimal inflammatory response adjacent to ProRoot and 
Portland cement were observed, suggesting both materials were well tolerated. He 
concluded that MTA and Portland cement show comparative biocompatibility when 
evaluated in vitro and in vivo.  
 
 Razmi et al (2004)44 evaluated the tissue reaction to implanted MTA and  
Portland cement in the mandible of cats. The physical and histological results 
observed with MTA were similar to those of Portland cement. Both the materials were 
considered  biocompatible. 
 
 Renato Menezes et al (2004)45 investigated the pulpal response of dogs’ 
teeth after pulpotomy and direct pulp protection with MTA Angelus, ProRoot, 
Portland cement and WPC. All the materials demonstrated similar results when used 
as pulp capping materials. Pulp vitality was maintained in all specimens and the pulp 
had healed with a hard tissue bridge. The study concluded that Portland cement  and 
MTA were equally effective as pulp protection materials following pulpotomy.  
 
 Durate et al (2005)7 concluded that the release of arsenic from Portland 
cement and MTA were similar and were well below those considered to be harmful. 
 
  Islam et al (2005)25 compared the major constituents present in ProRoot 
MTA, ProRoot MTA(tooth coloured) and ordinary Portland cement and white 
Portland cement using powder X-ray diffractometery. The main constituents were 
found to be tricalcium silicate, tricalcium aluminate, dicalcium silicate and 
tetracalcium aluminium ferrite in all the four cements with the additional presence of 
Bi2O3 in Pro Root MTA and Pro Root MTA (tooth coloured).  
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 Daniel Araki Ribeiro (2005)15 evaluated the genotoxic and cytotoxic effects 
of MTA and Portland cements in vitro using the alkaline single cell gel (comet) assay 
and trypan blue exclusion test, respectively on mouse lymphoma cells. The results 
demonstrated that the single cell gel assay failed to detect DNA damage after a 
treatment of cells by MTA and Portland cement. The study concluded that none of the 
compound tested were cytotoxic. 
 
 Marilia Gerhardt de Oliveira et al (2007)33 analyzed and compared Portland 
cement with MTA. Similar chemical elements were found in all materials and there 
was a small percentile variation among them. Bismuth was detected only in MTA 
composition. In spite of the chemical similarity, it was observed that there was 
difference in the texture and in the particles of each material. Pro Root MTA 
presented the highest percentage of bismuth (9.2% on average). Except for bismuth, 
Portland cement and MTA presented similar chemical formulations.  
 
 De Deus et al (2007)16 compared the sealing ability of four hydraulic cements, 
including Pro Root MTA and Portland cement. He concluded that no cement was 
capable of producing a fluid tight seal and the sealing ability promoted by MTA and 
Portland cement was similar.  
 
 Augusto Bodanezi et al (2008)5 investigated the solubility of Mineral 
Trioxide Aggregate and Portland cement. Only Portland cement showed less than 3% 
weight loss through 24 hours. Detached MTA residues were heavier than those of 
Portland cement over the 3 to 168 hours. The study concluded that in an aqueous 
environment MTA was more soluble than Portland cement and exceeds the maximum 
weight loss considered acceptable by ISO 6876 (2001). 
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 Bramante (2008)8 analysed the concentration of arsenic in Portland cement 
and MTA. He concluded that the concentrations were well below the limit set in ISO 
9917-1.  
 
 Amir Shayegan et al (2009)3 compared the response of the pulp of primary 
pig teeth after capping with beta-tricalcium phosphate, white MTA, white Portland 
cement and calcium hydroxide. There was no significant difference between the 
materials in terms of primary pulp response, hard tissue formation and normal pulp 
tissue preservation. Beta-tricalcium phosphate, WMTA and White Portland cement in 
primary pig teeth were as effective as Ca(OH)2 in pulp capping.  
 
 Taisa Regina Conti et al (2009)55 reported two clinical cases in which 
Portland cement was applied as a medicament after pulpotomy of mandibular primary 
molars. At the 12 month follow up, clinical and radiographic examinations of the 
pulpotomized teeth and their periradicular area revealed that the treatments were 
successful in maintaining the teeth asymptomatic, preserving pulp vitality and 
formation of a dentin bridge immediately below the Portland cement. 
 
 Antonio Vinicius Holanda Barbosa et al (2009)4 evaluated the short term 
response of human pulp tissue when directly capped with Portland cement. Portland 
cement exhibited some features of biocompatibility and capability of inducing mineral 
pulp response in short term evaluation. The results suggested that the Portland cement 
had a potential to be used as a less expensive pulp capping material in comparison to 
other pulp capping materials.  
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Radiopacifying Agents with Portland Cement 
 
 Coomaraswamy et al (2007)14 investigated the effect of 0 to 10% bismuth 
oxide radiopacifier addition on the material properties of an endodontic Portland 
cement based system. The study concluded that the addition of Bi2O3 radiopacifier 
decreased mechanical stability by introducing flaws and increased porosity by leaving 
more unreacted water within the Portland cement. Flaws in the set cement matrix 
might exacerbate existing cracks ; moreover increased porosity is known to increase 
the solubility and thus the degradation of the material. This might potentially affect 
the longevity of the material, compared to that of pure Portland cement, because the 
set material was more likely to degrade and was thus more likely to be compromised 
as a sealant. 
 
 Camilleri (2007)10 stated that the addition of bismuth oxide to MTA had been 
shown to affect the hydration mechanism of MTA. It forms part of the structure of 
calcium silicate hydrate, which was the main by product of cement hydration and also 
affects the precipitation of calcium hydroxide in the hydrated paste.  
 
 Marco Antonio Hungaro Durate et al (2008)32 evaluated the radiopacity of 
Portland cement associated with the following radiopacifying agents: bismuth oxide, 
zinc oxide, lead oxide, bismuth subnitrate, bismuth carbonate, barium sulphate, 
iodoform, calcium tungstate and zirconium oxide. A ratio of 20% radiopacifier and 
80% white Portland cement by weight was used for analysis. The study concluded 
that radiopacity of pure Portland cement was significantly lower than that of dentin. 
All the materials evaluated in the study had radiopacity values above that of dentin 
and the minimum recommended by ANSI/ADA.  
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 Carlos Eduardo da Silveira Bueno et al (2009)13 determined the ideal 
concentration of bismuth oxide in white Portland cement to provide it with sufficient 
radiopacity for use as an endodontic material (ADA specification #57). The readings 
of MTA and White Portland Cement with 15% bismuth oxide did not differ 
significantly from the reading observed for a thickness of 4mm of aluminium, which 
is considered ideal. White MTA and White Portland Cement with 15% bismuth oxide 
presented the radiopacity required for endodontic cement.   
 
 Saliba E et al (2009)50 evaluated the strength and radiopacity of Portland 
cement with varying additions of bismuth oxide. He concluded that the addition of 
bismuth oxide did not seem to affect the compressive strength of Portland cement. All 
the bismuth oxide (10% to 30%) replaced cements had radiopacities higher than 3mm 
thickness of aluminium.  
 
 Yun Chan Hwang et al (2009)66 compared the chemical constitution, 
radiopacity, and biocompatibility of Portland cement containing bismuth oxide with 
those of Portland cement and MTA. The chemical constitution was determined by 
energy-dispersive X ray analysis (EDX) attached to a scanning electron microscope. 
Cytotoxicity was evaluated using MTT assay. Tissue reaction was studied by 
subcutaneous implantation of the materials loaded in polyethylene tubes in the dorsal 
region of rats. The study concluded that the constitution of all materials were similar. 
However, the Portland cement were more irregular and had a larger particle size than 
MTA. The MTT assay revealed MTA to have slightly higher cell viability than the 
other materials. There was no significant difference in the tissue reaction between the 
experimental groups.  
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 Camilleri (2010)11 investigated the physical and chemical properties of 
Portland cement loaded with alternative radiopacifying materials (barium sulphate, 
gold and silver/tin alloy)  for use as root end filling materials in a mineral trioxide 
aggregate like system. It was concluded that the bismuth oxide in MTA could be 
replaced by gold and silver/tin alloy. The physical, mechanical and chemical 
properties of the cement replaced with alternative radiopacifiers were similar and 
comparable to ProRoot MTA.  
 
Cytotoxicity and Osteogenic Potential 
 
Sema S. Hakki et al (2009)52 investigated the effects of mineral trioxide 
aggregate (MTA) on survival, mineralization, and expression of mineralization-
related genes of cementoblasts. MTT assay was performed to evaluate bioactive 
components released by MTA (0.002-20 mg/mL) on the cell survival. Gene 
transcripts for bone sialoprotein (BSP), OCN, collagen type I (COL I), and 
osteopontin (OPN) were evaluated by using qRT-PCR. They concluded that MTA did 
not have a negative effect on the cell survival and morphology of cementoblasts but 
MTA induce biomineralization of cementoblasts. 
 
 Yuan et al65 (2010) investigated the cytotoxicity of bioaggregate (BA) and 
the effect of BA on mineral associated gene expression in osteoblast cells. The 
cytotoxicity of BA to mouse MC3T3-E1 osteoblast cells was evaluated via the MTT 
assay  and the expression of mineral associated genes was assessed by qRT-PCR and 
compared with mineral trioxide aggregate (MTA). They found that the expression of 
collagen type 1, osteocalcin, and osteopontin genes significantly increased in the BA 
group compared with that in the MTA group on the second or third day of culture. 
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S. Rajan et al47 (2008) determined in vitro assessment of MG-63 human 
osteosarcoma cells' alkaline phosphatase (ALP) activity when in contact with calcium 
hydroxide powder (CH), paste (CHP) and grey mineral trioxide aggregate (GMTA). 
BCIP-NBT assay was used and ALP activity quantified using ELISA reader at 410 
nm. They concluded that all three materials exhibited increased ALP activity. 
 
Deller-Quinn and Perinpanayagam17 (2009) determined the attachment of 
osteoblasts to MTA surfaces and alteration in their expression of inflammatory 
cytokines by qRT-PCR. They found that Cells on MTA surfaces produced IL-6 but 
failed to express IL-1 despite LPS stimulation. They concluded that Osteoblast 
expression of inflammatory cytokines is altered on endodontic MTA surfaces. 
 
Yan et al63 (2010) investigated the cytotoxicity of bioaggregate to human 
periodontal ligament (PDL) fibroblasts and its effect on differentiation of human PDL 
fibroblasts and compared its performance to that of mineral trioxide aggregate. 
Cytotoxicity was assessed by MTT assay and gene expression of alkaline phosphatase 
(ALP) and collagen type I (COLI) was evaluated via qRT-PCR. They concluded that 
the Gene expression of COLI and ALP was induced by both BA and MTA compared 
to the control group. 
 
Modareszadeh et al36(2012) evaluated the cytotoxicity and alkaline 
phosphatase (ALP) activity of a new bioceramic root repair material, EndoSequence 
Root Repair Material and compared these characteristics with those of ProRoot MTA. 
Cytotoxocity was assessed by MTT assay and ALP activity of the cells was evaluated 
using a methylthiazol sulfophenyl assay. They concluded that EndoSequence Root 
Repair Material in general reduced the bioactivity and ALP activity of osteoblast cells 
whereas MTA had no effect on the cells. 
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Experimental Materials Used: 
 
Pro Root MTA (Dentsply, U.S.) 
Birla White cement (Grasim Ind Ltd. Aditya Birla group) 
Bismuth Oxide LR (Chen Chemicals, India) 
Iodoform (Vikash Pharma, India) 
Zirconium dioxide (Lobal Ltd, India) 
 
Armamentarium for Assessing Cyototoxicity 
• Monolayer culture in log phase (MC3T3-E1) 
• Minimal Essential Media (MEM) without 10% fetal calf serum (FCS) 
• MTT reagent. 
• TPVG reagent (100 ml) 
• PBS                                - 84mL 
• 2%trypsin                        -5mL 
• 0.2%EDTA                      -10mL 
• 10%glucose                      -500µL 
• Penicillin & streptomycin   -500µL 
• EDTA 
• Fetal Calf Serum 
• Dimethyl sulfoxide 
• 0.4µ filter 
• 5ml sterile storage vial 
• Discarding  jar, Tissue paper, spirit, cotton, marker pen and gloves 
• Micropipette and tips 
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Armamentarium used for Alkaline Phosphatase Assay 
• Monolayer culture bottle of MC3T3-E1 cell lines 
• 5ml, 10ml, serological pipette   
• Phosphate buffer saline (PBS) 
• p- Nitrophenyl phosphate  
• Sodium hydroxide  
• UV Spectrophotometer (UV/VIS Digital spectrophotometer, Deep vision) 
 
Armamentarium used for Genetic Studies 
a) Chemicals used for qRT-PCR analysis. 
 Dulbecco‘s Modified Eagle‘s Medium (DMEM), Chloroform, Isopropanol, 
Agarose, Tris, Glycine, EDTA, Boric acid, Ethidium bromide, Trizol kit, Alizarin red, 
Cetylpyridinium, Oligonucleotide primers - Bone sialoprotein (BSP), Osteopontin 
(OPN), Osteocalcin (OCN), Collagen I (COL I), and Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) were purchased from Sigma, St. Louis, USA. Trypsin-
EDTA solution, Sodium bicarbonate, Fetal bovine serum (FBS), Amphotericin B, 
Penicillin-Streptomycin were purchased from GIBCO-BRL, New York. Formalin and 
Ethanol were purchased from Sisco Research Laboratories (SRL) Pvt. Ltd, Mumbai, 
India. Gel loading dye was purchased from Geni, Banglore. Phosphate buffer saline 
(PH 7.4). 
    b) Armamentarium for qRT-PCR analysis. 
Eppendorf tube, Cell Scraper, Thermal cycler (PCR machine), Electrophoresis 
Unit (Bio-Rad), Biofuge (Thermo), Microwave oven, Gel documentation system 
(Bio-Rad), UV visible spectrometer. 
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I. Methodology for Cytotoxicity 
 
A.) Minimal Essential Media (MEM) Preparation: 
            The MEM vial is dissolved in the pre sterilized Millipore distilled water and 
mixed well, closed and sterilized at 15lbs at 121ºC   for 15mins. Allow ingredients in 
the quantity, depending on the concentration of fetal calf serum (2% or 10%) mix well 
by shaking. Take care to avoid spills.  Pass CO2 using sterile pipette, shake the bottle, 
check pH and adjust to 7.2 to 7.4. The MEM bottles are kept for 2 days at 37ºC and 
checked for sterility, pH drop and floating particles. They are then transferred to the 
refrigerator (-20 C). 
 
B.) Cell Culture: 
Mouse osteoblastic Cells lines MC3T3-E1 were obtained from the National centre for 
cell sciences, Pune. Cells were cultured in Minimal Essential Medium (MEM) 
supplemented with 10% heat inactivated Fetal bovine serum (FBS), 3% L- glutamine, 
100 U/ml penicillin G and 100 µg/ml streptomycin (Hi media) grown at 37°C in a 
humidified atmosphere of 5% CO2 in air. 
 
C.) Subculturing and Maintenance of Cell Line: 
• The MEM Medium and TPVG which were maintained at -200 C were brought 
to room temperature for thawing. 
• The tissue culture bottles were observed for growth, cell degeneration, pH and 
turbidity through an inverted microscope (100 X). After attaining 80% 
confluence of cells, sub culturing was done. 
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• The mouth of the bottle was wiped with cotton soaked in spirit to remove the 
adhering particles. The growth medium was discarded in a discarding jar.  
• 4 – 5 ml of MEM without FCS was then added and gently rinsed with tilting. 
The dead cells and excess FCS were washed out and the medium was then 
discarded. 
• TPVG was added over the cells and incubated at 37º C for 5 minutes for 
dissaggregation.  The cells became individual and presented as suspension. 
• 5ml of 10% MEM with FCS was added by using serological pipette. Gentle 
passaging was given by using serological pipette. (Process was repeated if any 
clumps were present.) 
• After passaging, cells were splitted into 1:2, 1:3 ratios for cytotoxicity studies 
and were followed by plating method. 
 
D.) Determination of Material Concentration 
The Portland cement was mixed with three different Radiopacifying agents in 
4:1 ratio by weight and grouped with MTA and Control as follows, 
Experimental groups: 
GROUP I  -  Control 
GROUP II  - MTA  
GROUP III - White Portland Cement 80wt% + Iodoform 20wt% 
GROUP IV - White Portland Cement 80wt% + Zirconium Dioxide 20wt%                           
GROUP V  - White Portland Cement 80wt% + Bismuth Oxide 20wt% 
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· 0.5mg of each experimental material was dissolved in 4.5 ml of DMSO to give 
a working concentration of 10mg/ml. The working concentration was prepared 
fresh and filtered through 0.45 µfilter before each assay. 
· 500µl of MEM without FCS was taken in 9 eppendorf tubes. 
· Then 500µl of the working concentration (10 mg/ml) was added to the first 
eppendroff tube and mixed well.  Then 500µl of this volume was transferred 
from first to last tube by serial dilution to obtain 10 desired different 
concentration of the each material (10 mg/ml, 2 mg/ml, 1 mg/ml, 0.5 mg/ml, 
0.2 mg/ml, 0.1 mg/ml, 0.05 mg/ml, 0.02 mg/ml, 0.01 mg/ml, and 0.002 
mg/ml). 
· As a result the volume remained constant but there was a change in 
concentration. 
 
E.) Sampling: 
Totally twenty 24 well culture plates were used. From those 20 plates, 2 plates 
were selected for each concentration of the experimental materials of 10 different 
concentrations (10 X 2). Two plates were further divided into 9 wells for each group 
of 4 groups (n=9, 4 groups, total 36 wells). Control group (Group I) was placed (n=9) 
in any one of the plates.  
 Ten different concentrations were 10 mg/ml, 2 mg/ml, 1 mg/ml, 0.5 mg/ml, 
0.2 mg/ml, 0.1 mg/ml, 0.05 mg/ml, 0.02 mg/ml, 0.01 mg/ml, and 0.002 mg/ml. 
Schematic Illustration of Sampling 
For example, 10 mg/ml concentration of sample materials were added into two 
24 well plates in 9 wells for each group of 4 groups (n=9, 4 groups, 36 wells). Control 
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group was placed here (n=9) and was not placed in any other plates. The following 
pictures describe the method of sampling of 5 groups (Group I –V) 
 
Figure 1: Two 24 well Culture plates 
 
      
 
  
48hr monolayer culture of cells (MC3T3-E1) at a concentration of one lakh /ml /well 
seeded in all twenty 24 well culture plates. 1ml of medium (without FCS) containing 
defined concentration of the experimental material was added in twenty 24 wells so 
that each group at each specific concentration were placed in 9 wells (n=9). To the 
cell control wells (n=9) 1ml MEM without FCS was added. The plates were incubated 
at 37ºc in 5% CO2 environment and observed for cytotoxicity at 24, 48 and 72 hrs 
using MTT assay. 
 
F.)MTT assay  
MTT assay is a colorimetric assay that measures the reduction of 3-(4, 5-
dimethyl thiazol-2yl)-2, 5-diphenyl tetrazolium bromide (MTT) by mitochondrial 
succinate dehydrogenase enzyme. The MTT salt enters the cells and passes into the 
mitochondria where it is reduced to insoluble purple formazan product upon cleavage 
of the Tetrazolium by dehydrogenase enzyme. The cells were then solubilised with an 
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organic solvent and the pink solubilised formazan reagent was measured 
spectrophotometrically at 570 nm. Reduction of MTT can occur only in metabolically 
active cells and the level of activity is a measure of the viability and proliferation of 
the cells. Results were recorded as optical density (OD) units and a decrease in OD 
value denotes decrease in cell viability (i.e) increase in cytotoxicity. 
 
II. Determination of Best Sample Material Concentration 
 
The values were obtained for MTT assay for all ten concentrations and were 
recorded. The values were analyzed by cell viability percentage by using the formula 
{A/C * 100}, where A = OD values of experimental group and C=OD values of 
control group using Microsoft Excel 2010. 
 The concentrations of all experimental materials including 10, 2, 1, 0.5, 0.2, 
0.1 and 0.05 mg/ml showed increased cell survival of osteoblasts from 24 to 72 hrs. 
But 0.02, 0.01 and 0.002 mg/mL concentrations of all experimental materials 
remarkably increased cell survival of osteoblasts (cell viability percentage of 80%) 
when compared with the other concentrations of MTA from 24 to 72 hrs. (This is 
consistent with results of Sema S. Hakki et al. 2009 50) 
 Hence the best concentration for all experimental materials was chosen as 0.02 
mg/ml (minimum dilution with best cell survival ability) and was used for alkaline 
phosphatase assay and qRT-PCR analysis. 
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III. Methodology for Alkaline Phosphatase (ALP) Assay 
 
 Osteoblast cells MC3T3E1 were grown to confluence and treated with 
different experimental material samples at a concentration of 0.02mg/ml. At defined 
time points, 3, 7 and 15 days, cells were harvested by scraping, rinsed twice with PBS 
and resuspended in lysis buffer (50 mM Tris, 100 mM glycine, 0.1% Triton X-100, 
2.0 μg/ml aprotinin, 2.0 μg/ml leupeptin, 1.0 μg/mg pepstatin, pH 10.5). Cells were 
placed on ice, lysed by sonication and the lysate centrifuged at 15,000  rpm for 5 min 
at 4 °C. Supernatants were then assayed for total protein content by the Bicinchoninic 
Acid (BCA) Assay and 30 μg of total protein was used to measure alkaline 
Phosphatase activity. Supernatants were incubated with substrate solution (3 mM p-
nitrophenol phosphate, 0.7 M 2-amino-2-methyl-1-propanol, 6.7 mM MgCl2, pH 
10.3) for 30 min at 37 °C and then quenched by addition of 100 μL of 1N sodium 
hydroxide. Reactions were measured for optical density at 405 nm using a 
spectrophotometric plate reader. 
 
IV. Quantitative Reverse Transcriptase - Polymerase Chain 
Reaction (qRT-PCR)  Analysis of mRNA Expression  
 
The experimental materials at a concentration of 0.02 mg.ml were added into two 
24 well culture plates (total no of wells - 45, n = 9 for each group of 5 groups). Mouse 
osteoblast cells (MC3T3-E1) were then seeded at 1 lakh cells per well in DMEM with 
10% FBS on the material mixed wells and cultured for 24, 48 and 72 hrs.  
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A.) Isolation of Total RNA  
Total RNA was isolated from control and material treated cells by using total RNA 
isolation reagent (Trizol, Medox) kit following the method of Chomczynski and 
Sacchi (1987).  
Principle 
       Single step guanidium acid phenol method emphasizes on the ability of 
guanidium isothiocyanate (GITC) to lyse tissues, denature protein and inactivate 
intracellular ribonuclease rapidly. The presence of β-mercaptoethanol in the mixture 
enhances the solubilization properties of the GITC extraction buffer. Acid phenol 
extraction (pH< 5.0) selectivity retains cellular DNA in the organic phase and aids in 
extraction of proteins and lipids. The addition of chloroform further removes lipids 
and establishes two distinct phases containing the DNA, proteins and lipids and an 
aqueous phase containing the RNA. The aqueous phase is separated and the RNA was 
precipitated by adding equal volume of isopropanol. 
 
Reagents  
     Trizol kit has the following components: 
• Phenol, guanidium isothiocyanate, urea, detergents, buffering agents and 
stabilizers. 
• Chloroform (molecular biology grade). 
• Isopropanol (molecular biology grade). 
• 75% ethanol -To 7.5mL of absolute ethanol, 2.5mL of autoclaved deionised 
water. 
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Procedure 
      1 ml Trizol was added to control and material treated cells and swirled gently for 
15 min and then kept at 4ºC for 5 min to permit complete dissociation of 
nucleoprotein complexes. To this 200 micro litre of chloroform was added, shaken 
vigorously for 15 seconds and placed on ice at 4ºC for 5 min. The lysate was then 
centrifuged at 12,000 rpm for 15 minutes at 4ºC, which yielded lower organic phase 
containing DNA and proteins and upper aqueous phase containing RNA. The volume 
of the aqueous phase was about 40-50% of the total volume of the lysate. 
     The aqueous phase was carefully transferred to a fresh eppendorf micro centrifuge 
tube without disturbing the interphase. Equal volume of isopropanol was added, 
mixed and kept at 4ºC for 10 min. It was again centrifuged at 12,000 rpm for 10 
minutes at 4ºC to precipitate the RNA. 
     The supernatant was removed and the pellet was washed twice with 75% ethanol 
and air dried and centrifuged at 7500 rpm for 5 minutes. The RNA pellet was then 
dissolved with 25 µl of sterile deionised water and placed in a water bath at 60ºC for 
10 minutes to ensure maximum solubility of RNA. The RNA sample was 
subsequently vortexed gently and quantified before storing at -80ºC. 
 
B.) Quantification of RNA 
     Diluted RNA sample was quantified spectrophotometrically by measuring the 
absorbance (A) at 260 nm. An absorbance of 1OD is equivalent to RNA concentration 
of 40 g/ml. Therefore, the yield can be calculated by multiplying the absorbance at 
260 nm with dilution factor and 40. The purity of RNA preparations were assessed by 
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determining the ratio of absorbance of sample at 260 nm and 280 nm. The purity of 
RNA obtained was ~1.6-1.8. 
 
C.) Reverse Transcriptase-Polymerase Chain Reaction  
 The reverse transcriptase-polymerase chain reaction (RT-PCR) involves the 
conversion of mRNA present in the total RNA into cDNA and then amplifies a 
specific region of interest present in the cDNA. Reverse transcriptase-polymerase 
chain reaction of BSP, OPN, OCN, COL I, TNF-α, IL-6, IL-1α, and GAPDH were 
performed using Qiagen two step RT-PCR kit. This enzyme reverse transcriptase 
catalyzes the conversion of mRNA into cDNA. Reverse transcriptase polymerase 
chain reaction was done using a two step kit in which the reverse transcription 
reaction and the amplification can be carried out separately. 
 
Principle 
     RT-PCR selectively amplifies the first strand of cDNA that has been synthesized 
in vitro from mRNA templates by reverse transcription. The cDNA is first denatured 
by heating in the presence of two oligonucleotide primers and four dNTPs. The 
reaction mixture is then cooled to allow the oligonucleotide primers to anneal to their 
target sequences, after which the annealed primers are extended with DNA 
polymerases. 
 
Reverse Transcription 
     2µg of total RNA isolated control and experimental groups were subjected to 
reverse transcription using Qiagen kit, Germany.  The components include , 
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• Volume of buffer     : 2 µl 
• dNTP       : 2 µl 
• Oligo dT(10 µM)     : 2 µl 
• RT enzyme      : 1 µ1 
• RNA       : Variable (2μg) 
• Water       : Variable 
---------------- 
• Total      :    20 µl  
 
Polymerase chain reaction 
Description 
      PCR Master mix includes Nuclease-free water and PCR Master mix, 2X. PCR 
Master mix is a premixed, ready to use solution containing Taq DNA polymerase 
dNTPs, MgCl2 and reaction buffers at optimal concentrations for efficient 
amplification of DNA templates by PCR. 
PCR Master Mix, 2X 
     50 units/ml of Taq DNA polymerase supplied in a proprietary reaction buffer (pH 
8.5), 400μM dATP, 400μM dCTP, 400μM dTTP, 400μM dGTP, 3mM MgCl2. 
General Reaction Protocol 
     The components in the PCR include 
Component Volume Final Conc. 
2 X PCR master mix 12.5μl 1X 
Upstream Primer  (6μM) 2.5 µl 0.6 μM 
Downstream Primer (6μM) 2.5 µl 0.6 μM 
Upstream Primer(GAPDH) (6μM) 1 µl 0.25μM 
Downstream Primer(GAPDH) (6μM) 1 µl 0.25μM 
Template DNA 1 µl 1 in 10 dilution 
Water 4.5μl - 
Total Volume                                                 25 μl - 
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       The reaction mix was centrifuged in a microcentrifuge for 10 seconds and placed 
in a thermal cycler. PCR was performed using standard procedures (3-step Cycling). 
The PCR products were separated using agarose gel electrophoresis and visualized 
and documented using quantity one software (Bio Rad, USA). 
Oligonucleotide primers  
     For amplification of the target genes, the following primers were used. 
 
S.NO PRIMERS 
1. BSP 
 Forward 5 ‘- CAGGGAGGCAGTGACTCTTC-3’ 
Reverse  5’-AGTGTGGAAAGTGTGGCGTT-3’ 
2. OPN 
Forward 5 ‘-GTCAAGCAGGAGTGCAATCG-3’ 
Reverse  5’- GTCAAGCAGGAGTGCAATCG-3’ 
3. 
 
OCN 
    Forward 5 ‘-CTGACAAAGCCTTCATGTCCAA-3’ 
    Reverse  5’- GCGCCGGAGTCTGTTCACTA-3’ 
4. COL I 
    Forward 5'-CCTGGTAAAGATGGTGCC-3' 
    Reverse  5'-CACCAGGTTCACCTTTCGCACC-3' 
5. TNF-α 
Forward 5 ‘-CCACCACGCTCTTCTGTCTAC-3’ 
Reverse  5’- AGGGTCTGGGCCATAGAACT-3’ 
6. IL-1α 
Forward 5 ‘-TTGACAAACAAATTCGGTACA--3’ 
Reverse  5’-  GAGGTGCCCATGCTACA-3’ 
7. IL-6 
Forward 5 ‘-TTGACAAACAAATTCGGTACA--3’ 
Reverse  5’-  GAGGTGCCCATGCTACA-3’ 
 
8. 
GAPDH     
Forward 5 ‘-AGGTCGGTGTGAACGGAT TTG-3’ 
Reverse  5’- TGTAGACCATGTAGTTGAGGTCA-3’ 
 
D.) Agarose Gel Electrophoresis 
     Agarose Gel Electrophoresis is an effective method for the identification of DNA 
molecules (Sambrook et al., 1989). 
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Principle 
     The generated cDNA fragments were resolved in 2% agarose gel under an applied 
electric field. DNA molecules migrate towards the anode due to negatively charged 
phosphate along the backbone of DNA. The rate of migration of linear DNA is 
inversely proportional to its molecular weight. Thus, the larger molecules travel at a 
much lower speed when compared to smaller one. 
 
Reagents 
• TBE buffer 1X: (Tris, Boric acid,  EDTA) (pH 8.0): 5.4 g tris, 2.75 g boric 
acid and 370mg of EDTA were dissolved in 500 ml of autoclaved RNAse and 
DNAse free water and the pH was adjusted to 8.2. 
• 1% Ethidium bromide (EtBr) in RNAse and DNAse free water  
• 2% Agarose in 1 X TBE buffer:  1g of agarose was transferred to a conical 
flask containing 50ml of 1 X TBE buffer, melted in a oven to ensure complete 
solubility. 
• Gel loading dye (6 X) 
            The gel loading dye (6 X) was procured commercially in ready to use 
form.             
 
Procedure  
      1 g of agarose was added to 50 ml 1 X TBE buffer (2%). It was then melted in a 
microwave oven, the volume was made up to 50 ml with TBE buffer and 2 μl of 1% 
EtBr was added, evenly mixed and cooled to 40ºC. It was then poured into a sealed 
gel-casting platform and comb was inserted after ensuring the absence of air bubbles. 
The gel was then allowed to harden. After 45 minutes, the comb was removed taking 
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care that the sample wells were not disturbed. The platform was then immersed in the 
tank with electrophoresis buffer. 
        5 μl of PCR products from each reaction tube was mixed with 2 μl of 6X gel 
loading dye and loaded to each well. A 100 bp molecular weight marker DNA was 
simultaneously loaded in the first lane to check the specificity of the product. The 
power supply was turned on and the current adjusted to 80-100 mA, for 2 hours, and 
then the resolved cDNA fragments in the gel were visualized and documented using 
Quantity one software (Bio-Rad, USA). The band intensity of resolved cDNA 
fragments of BSP, OPN, OCN, TNF-α, IL-1α, IL-6 were normalized with that of the 
internal control GAPDH and expressed as OD units relative to GAPDH.     
 
E.) Stimulation with Bacterial LPS 
 
Experimental Groups  
GROUP I  -  Control 
GROUP II  - LPS alone  
GROUP III     -           LPS + MTA  
GROUP IV - LPS + White Portland Cement 80wt% + Iodoform 20wt% 
GROUP V - LPS + White Portland Cement 80wt% + Bismuth Oxide 20wt% 
GROUP VI  - LPS + White Portland Cement 80wt% + Bismuth Oxide 20wt%                                     
 
Mouse MC3T3-E1 preosteoblasts (100,000 cells per well) were seeded onto 
0.02 mg/ml of sample mixed three 24-well tissue culture plates (n=9, 6 groups & 54 
wells). After 6 hours of growth, fresh medium was added containing 10 micro g/mL 
LPS in all the groups except group I which serves as a control. The LPS were 
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obtained from Escherichia coli. After 24, 48 and 72 hrs hours of incubation, replicate 
cultures were harvested for RNA extraction and reverse-transcription polymerase 
chain reaction (RT-PCR) analysis was performed as mentioned above. 
 
Statistical Analysis 
 
     The values were recorded for each group. The values were analyzed statistically by 
One Way Analysis of Variance followed by multiple comparison Tukey HSD test. All 
statistical analyses were done using SPSS 11.5. Statistical significance was 
determined at P < 0.05.  
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FLOW CHART 
Procedural flowchart for assessing Cytotoxicity 
MTT ASSAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 h after plating, cells were washed twice with 100 µl of MEM 
and grown at 37°C in a humidified atmosphere of 5% CO2 in air. 
The MC3T3-E1cells were plated in twenty 24 well plates at a 
concentration of One lakh /ml /well. 
Material were mixed at a concentration of 10 mg/ml and 500µl of 
this  volume was transferred from first to last tube  by serial 
dilution to obtain the 10 desired concentration of the material. 
(10 mg/ml, 2 mg/ml, 1 mg/ml, 0.5 mg/ml, 0.2 mg/ml, 0.1 mg/ml, 
0.05 mg/ml, 0.02 mg/ml, 0.01 mg/ml, 0.002mg/ml). 
Then samples were added into twenty 24 well plates (9 for each 
groups of 4 groups) and for every different concentration (10 
different concentrations for each group of 4 groups) 
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 Group II 
MTA 
( n=9) 
Group III  
PC+CHI3 
( n=9) 
GroupIV 
PC+ZrO2 
( n=9) 
Group V 
PC+Bi2O3 
( n=9) 
The medium was discarded and 100 µl of MTT containing DMEM 
medium was added to each well. The cells were then incubated for 3 hrs. 
The MTT containing medium was then discarded and washed with 
MEM and then the crystals were dissolved by adding 1 ml of DMSO. 
The test samples were rinsed twice with MEM and placed into 24-well  
plates for 24, 48  and 72 hrs and incubated at 37º C. 
The optical density values were measured using UV 
Spectrophotometer at 570 nm. 
Group I 
Control 
( n=9) 
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ALP ASSAY                                                                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One lakh /ml MC3T3-E1 cells were seeded on test material wells under 
culture conditions in osteogenic medium 
 
The cells were scraped out from the cells using trypsin/EDTA, washed 
twice with PBS & resuspended in lysis buffer and centrifuged at 15,000 
rpm for 5 min at 4 °C. 
Cell lysate was obtained & total protein content was assessed by BCA 
assay. Then 30 micro gram of protein was used to assess the ALP activity 
by using p-nitro phenyl phosphate as the substrate. 
The reaction was stopped by the addition of 1 N NaOH to reaction mixture. 
The absorbance at 405 nm (OD value) was measured using UV 
Spectrophotometer and was expressed as μ moles of r-nitrophenol / min / μg 
protein 
 
Test materials were added (0.02 mg/ml) & divided into 5 groups of 9 
wells each as mentioned for MTT assay 
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Procedural flowchart for qRT-PCR analysis 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
200μl of chloroform (for 1ml Trizol) was added & vortexed. After 5 
min, it was centrifuged at 12,000 rpm for 15 min at 4ºC.                  
[This step will separate RNA, DNA & Protein] 
LPS at a conc. of 10 micro g /ml was 
added to the wells mixed with 
materials and also to the wells without 
any material (Group II – LPS alone). 
At 24 hrs, 48 hrs and 72 hrs, 1ml Trizol was added to control and 
material treated cells and swirled gently for 15 min and then kept at 4ºC 
for 5 min to permit complete dissociation of nucleoprotein complexes.  
MC3T3-E1 cells were then seeded at 1 lakh cells per culture plate and 
cultured in incubator 
 
The experimental samples (0.02 
mg/ml) were added to two 24 well 
plates (n=9 for each group of 5 
groups for mineralization & 
cytokines assay) and incubated. 
The experimental samples (0.02 
mg/ml) were added to three 24 well 
plates (n=9 for each group of 6 
groups for LPS stimulated cytokines 
assay) and incubated. 
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The RNA pellet was washed with 1ml 75% Ethanol to remove any 
residual acidity and centrifuged at 7500 rpm for 5 min 
 
Then the aqueous phase (contains RNA) was transferred to fresh 
eppendorf tube & equal amount of Isopropanol was added & centrifuged 
at 12,000 rpm for 10 min. [This step will precipitate the RNA] 
The pellet was mixed with 25 μl sterile water 
Checked at A260 and A280 nm  
40μg of RNA when dissolved in 1ml gives 1OD  
Therefore the A260 when multiplied by 40 gives the conc. of RNA  
A260/A280 gives the purity of RNA (~1.6- 1.8)  
2μg of total RNA was Reverse transcribed (cDNA convertion)  
The cDNA was used for PCR analysis using gene specific Primer 
(BSP, OPN, OCN, COL I, TNF a, IL-1 a, IL-6 and GAPDH)  
The products were analyzed using Agarose gel electrophoresis for 
24, 48 and 72 hours. 
ARMAMENTARIUM FOR CYTOTOXICITY AND ALKALINE 
PHOSPHATASE ACTIVITY 
 
A) CELL CULTURE 
 
Fig 1& 2: MC3T3-E1 Cell line 
 
 
Fig 3: Inverted Phase contrast Microscope  
 
 
                            
           Fig 4: Minimal Essential Media                                 Fig 5: CO2   Incubator 
      with 10 % FCS 
  
B) MTT ASSAY 
 
   
              Fig. 6: MTT dye                                           Fig 7: Dimethyl  
Sulphoxide (DMSO) 
 
C) ALKALINE PHOSPHATASE ASSAY 
 
              
 
 
Fig 8: Aliquots (Supernatants) separated  
     
 
Fig 9 & 10: Reagents for Alkaline Phosphatase Assay 
 
METHODOLOGY FOR CYTOTOXICITY AND ALKALINE 
PHOSPHATASE ACTIVITY 
 
A) MAINTANENECE OF CELL CULTURE 
 
      
Fig 11: Washing of Samples with Medium                   Fig 12:  Placement of Cells 
 
 
 
B) MTT ASSAY 
 
 
 
                   Fig 13: Samples loaded with cells 
 
 
Fig 14: Colour change after MTT reaction 
 
Fig 15: UV Spectrophotometer Showing Reading 
  
C) ALKALINE PHOSPHATASE ASSAY 
 
 
                                     Fig 16: Aliquots placed in 24 well plate 
 
 
                               Fig 17: Colour change in Alkaline phosphatase reaction 
 
 
 
                            ARMAMENTARIUM FOR qRT-PCR ANALYSIS  
 
   
Fig 18 : Gel Documentation system                  Fig 19 : Biofuge (Thermo) 
            (Bio-Rad) 
 
                       
       Fig. 20 : Thermal cycler                              Fig. 21: Laboratory Microwave oven 
     (PCR Machine)   
 
    
Fig. 22: Electrophoresis unit                                Fig. 23: UV visible spectrometer. 
                      METHODOLOGY FOR qRT-PCR ANALYSIS  
  
Fig 24 : MC3T3-E1 cells seeded into                             Fig 25 : 1 ml of trizol is added and swirled   
culture plate                             for 5 min and kept at 4
0
C at 24, 48, 72 hrs. 
              
   
Fig. 26: To the aqueous phase(contains RNA)          Fig 27 : The mixture centrifuged in Biofuge at                     
equal amount of isopropanol is added                          12,000 rpm for 10 min to precipitate RNA 
   
Fig 28: Showing precipitated RNA pellet             Fig 29: RNA pellet dissolved in RNase and 
DNase free deionised water and  quantified 
before storing 
 
 Fig 30: 2μg of total RNA was Reverse transcribed (cDNA convertion) in thermocycler. 
Enzyme reverse transcriptase catalyzes the conversion of mRNA into cDNA 
 
Fig 31: Polymerase chain reaction was carried out by setting the annealing temperature 
and number of cycles 
 
Fig 32: The PCR products were separated using agarose gel electrophoresis 
 
Fig 33: The PCR products visualized using Quantity one software (Bio Rad). 
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I.Cytotoxicity 
 
 Table 1 : Mean ± SD of Cytotoxicity effect of samples  on Mouse 
osteoblastic cell line (MC3T3-E1) 
 
 
S.no Concentration 
(mg/mL) 
24 hrs 
MTA PC + CHI3 PC+ZrO2 PC+Bi2O3 
1 10 35.67±0.98 31.44±0.19 37.89±1.98 28.98±1.23 
2 2 38.91±0.78 41.32±0.43 40.56±0.78 35.16±0.78 
3 1 43.55±0.77 44.16±1.67 43.78±1.76 42.34±1.43 
4 0.5 45.89±0.12 46.45±1.98 47.78±0.98 46.90±0.78 
5 0.2 48.19±0.18 48.88±0.43 49.78±1.32 49.18±0.98 
6 0.1 55.17±0.32 53.21±1.21 51.67±0.54 54.66±1.32 
7 0.05 67.89±0.12 63.45±1.98 65.78±0.98 68.90±0.78 
8 0.02 72.16±1.67 73.61±0.58 72.32± 0.67 72.22± 0.77 
9 0.01 74.51±0.56 75.64±0.91 76.12±0.91 76.89±1.21 
10 0.002 83.66±0.91 85.78±0.65 86.78±0.43 84.32±1.89 
11 Cell control 86.99± 1.21 86.99± 1.21 86.99±1.21 86.99± 1.21 
S.no Concentration 
(mg/mL) 
48 hrs 
MTA PC + CHC3 PC+2rO2 PC+Bi2O3 
1 10 57.89±0.32 49.78±1.23 46.77±0.45 41.89±0.77 
2 2 59.08±0.97 54.87±0.76 51.77±0.31 45.67±1.21 
3 1 63.78±0.77 64.54±1.01 63.21±0.67 54.32±1.43 
4 0.5 64.23±0.12 65.16±0.76 66.46±1.89 55.54±0.81 
5 0.2 64.77±0.67 67.88±1.43 68.17±1.43 56.78±1.77 
6 0.1 71.56±0.78 71.32±0.54 73.17±1.54 64.32±0.87 
7 0.05 74.23±0.12 75.16±0.76 74.89±1.89 74.54±0.81 
8 0.02 79.42±.22 79.56±0.58 79.16± 0.32 79.48± 0.72 
9 0.01 81.55±1.49 84.13±0.65 85.11±1.23 89.19±0.78 
10 0.002 86.78±0.88 88.98±1.32 86.32±0.54 90.78±0.76 
11 Cell control 94.42± 0.22 94.42± 0.22 94.42±0.22 94.42± 0.22 
S.no Concentration 
(mg/mL) 
72 hrs 
 
MTA 
 
PC + CHI3 
 
PC+ZrO2 
 
PC+BI2O3 
1 10 81.33±0.54 78.91±1.49 80.78±0.91 83.43±1.22 
2 2 84.32±0.32 82.32±1.56 81.56±0.32 84.32±0.91 
3 1 84.89±0.67 85.67±1.32 87.65±0.76 86.43±1.43 
4 0.5 86.67±0.54 86.32±0.66 88.43±0.87 87.43±0.09 
5 0.2 87.43±1.09 89.78±1.7 89.17±0.54 89.76±1.43 
6 0.1 89.09±0.98 92.32±1.90 91.67±0.67 91.32±1.99 
7 0.05 91.67±0.54 93.32±0.66 93.43±0.87 93.43±0.09 
8 0.02 94.51± 0.73 94.25± 1.18 94.11± 1.36 94.9± 0.23 
9 0.01 95.67±0.12 98.78±0.62 98.17±0.13 99.17±0.89 
10 0.002 98.76±0.55 99.17±0.89 98.78±0.62 99.37±0.43 
11 Cell control 78.52+/- 0.78 78.52± 0.78 78.52±0.78 78.52±0.78 
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Interpretation : 
The mean +/- SD of all the OD values obtained from 10 different concentrations 
of all the experimental groups and cell viability percentage were calculated. The 
results were as follows, 
· The concentrations of all experimental materials including 10, 2, 1, 
0.5, 0.2, 0.1 and 0.05 mg/ml showed increased cell survival of 
osteoblasts from 24 to 72 hrs.  
· But 0.02, 0.01 and 0.002 mg/mL concentrations of all experimental 
materials remarkably increased the cell survival of osteoblasts when 
compared with the other concentrations of MTA from 24 to 72 hrs.  
· Hence the best concentration for all experimental materials was 
chosen as 0.02 mg/ml (minimum dilution with best cell survival 
ability) and was used to compare the cytotoxicity between the groups 
and also used for alkaline phosphatase assay and qRT-PCR analysis. 
 
Table 2. Mean +/- SD of MTT assay values at a concentration of 0.02 mg/ml 
of experimental samples at 24, 48 AND 72 HRS 
 CONTROL MTA PC + CHI3 PC + ZrO2 PC+Bi2O3 
24 HRS 86.99+/- 1.21 72.16+/- 1.67 73.61+/- 0.58 72.32+/- 0.67 72.22+/- 0.77 
48 HRS 94.42+/- 0.22 99.56+/- 0.58 99.16+/- 0.32 99.48+/- 0.72 99.76+/- 0.50 
72 HRS 78.52+/- 0.78 94.51+/- 0.73 94.25+/- 1.18 94.11+/- 1.36 94.9+/- 0.23 
 
Table 3. Oneway ANOVA 
 
    Sum of Squares df Mean Square F Sig. 
HRS24 Between Groups 
Within Groups 
Total 
502.768 
11.335 
514.103 
4 
10 
14 
125.692 
1.133 
  
110.892 
  
  
.000 
  
  
HRS48 Between Groups 
Within Groups 
Total 
58.900 
2.555 
61.455 
4 
10 
14 
14.725 
.255 
  
57.635 
  
  
.000 
  
  
HRS72 Between Groups 
Within Groups 
Total 
609.357 
8.958 
618.315 
4 
10 
14 
152.339 
.896 
  
170.062 
  
  
.000 
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Table 4. Post Hoc Tests -Multiple Comparisons - Tukey HSD  
 
Dependent 
Variable 
(I) 
GROUPS 
  
(J) 
GROUPS 
  
Mean 
Difference 
 (I-J) 
  
Sig. 
  
95% Confidence Interval 
  
HRS24  
  
  
  
  
  
  
  
  
Lower 
Bound 
Upper 
Bound 
control 
  
  
  
MTA 14.8267(*) .000 11.9658 17.6875 
PC + CHI3 13.3800(*) .000 10.5191 16.2409 
PC + ZrO2 14.6667(*) .000 11.8058 17.5275 
PC + Bi2O3 14.7733(*) .000 11.9125 17.6342 
MTA 
  
  
control -14.8267(*) .000 -17.6875 -11.9658 
PC + CHI3 -1.4467 .494 -4.3075 1.4142 
PC + ZrO2 -.1600 1.000 -3.0209 2.7009 
PC + Bi2O3 -.0533 1.000 -2.9142 2.8075 
HRS48 
   
  
  
  
  
  
  
control 
  
  
  
MTA 4.8567(*) .000 3.4984 6.2149 
PC + CHI3 5.2633(*) .000 3.9051 6.6216 
PC + ZrO2 4.9400(*) .000 3.5818 6.2982 
PC + Bi2O3 4.6600(*) .000 3.3018 6.0182 
MTA 
  
  
  
control -4.8567(*) .000 -6.2149 -3.4984 
PC + CHI3 .4067 .856 -.9516 1.7649 
PC + ZrO2 .0833 1.000 -1.2749 1.4416 
PC + Bi2O3 -.1967 .988 -1.5549 1.1616 
HRS72 
  
   
  
  
  
  
  
  
control 
  
  
  
MTA -15.9833(*) .000 -18.5266 -13.4400 
PC + CHI3 -15.7267(*) .000 -18.2700 -13.1834 
PC + ZrO2 -15.5900(*) .000 -18.1333 -13.0467 
PC + Bi2O3 -16.3800(*) .000 -18.9233 -13.8367 
MTA 
  
  
  
control 15.9833(*) .000 13.4400 18.5266 
PC + CHI3 .2567 .997 -2.2866 2.8000 
PC + ZrO2 .3933 .985 -2.1500 2.9366 
PC + Bi2O3 -.3967 .984 -2.9400 2.1466 
* The mean difference is significant at the .05 level. 
Interpretation:  
The mean +/- SD of all OD values at 0.02 mg/ml of experimental sample 
was obtained and statistical analysis was performed. The results were as 
follows, 
· The cell viability with the presence of all experimental groups was 
decreased on the first day and second day but increased 
significantly on the third day compared to the control 
group.(P<0.01) 
· There was a significant difference between the control group and 
all experimental groups at all experimental periods. (p<0.01). 
· There was no statistically significant difference between the 
experimental groups at all experimental periods. 
Inverted microscopic view of cell growth at 100 X magnification treated with 
0.02 mg/ml of MTA. 
 
24 hrs (0.02mg/mL)                        48 hrs (0.02mg/ml)                 72 hrs (0.02mg/ml) 
 
 
Inverted microscopic view of cell growth at 100 X magnification treated with 
0.02 mg/ml of PC + CHI3. 
 
24 hrs (0.02mg/mL)                        48 hrs (0.02mg/ml)                 72 hrs (0.02mg/ml) 
 
 
Inverted microscopic view of cell growth at 100 X magnification treated with 
0.02 mg/ml of PC + ZrO2. 
 
24 hrs (0.02mg/mL)                        48 hrs (0.02mg/ml)                 72 hrs (0.02mg/ml) 
 
 
Inverted microscopic view of cell growth at 100 X magnification treated with 
0.02 mg/ml of PC + Bi2O3. 
 
24 hrs (0.02mg/mL)                        48 hrs (0.02mg/ml)                 72 hrs (0.02mg/ml) 
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II.ALKALINE PHOSPHATASE ASSAY 
 
Table 5. Mean +/- SD of ALP values at 3, 7 and 15 days 
 
 
 
Table 6. Oneway ANOVA 
 
 
    Sum of Squares df Mean Square F Sig. 
DAY3 Between Groups 
Within Groups 
Total 
210.870 
41.932 
252.802 
4 
10 
14 
52.717 
4.193 
  
12.572 
  
  
.001 
  
  
DAY7 Between Groups 
Within Groups 
Total 
154.954 
26.107 
181.061 
4 
10 
14 
38.739 
2.611 
  
14.838 
  
  
.000 
  
  
DAY15 Between Groups 
Within Groups 
Total 
546.280 
47.097 
593.377 
4 
10 
14 
136.570 
4.710 
 
28.998 
  
  
.000 
  
  
 
 
Table 7. Post Hoc Tests - Multiple Comparisons -Tukey HSD  
 
 
Dependent 
Variable 
(I) GROUPS 
  
(J) GROUPS 
  
Mean Difference 
(I-J) 
  
Sig. 
  
95% Confidence Interval 
  
DAY3 
  
  
  
  
  
  
  
    
Lower 
Bound 
Upper 
Bound 
CONTROL 
  
  
  
MTA -8.3333(*) .004 -13.8359 -2.8307 
PC + CHI3 -10.3600(*) .001 -15.8626 -4.8574 
PC +ZrO2 -7.3833(*) .009 -12.8859 -1.8807 
PC + Bi2O3 -9.8733(*) .001 -15.3759 -4.3707 
MTA 
  
  
  
CONTROL 8.3333(*) .004 2.8307 13.8359 
PC + CHI3 -2.0267 .745 -7.5293 3.4759 
PC +ZrO2 .9500 .977 -4.5526 6.4526 
PC + Bi2O3 -1.5400 .882 -7.0426 3.9626 
DAY7 
  
  
  
  
  
  
  
CONTROL 
  
  
  
MTA -8.5833(*) .001 -12.9252 -4.2415 
PC + CHI3 -8.0167(*) .001 -12.3585 -3.6748 
PC +ZrO2 -5.1800(*) .019 -9.5218 -.8382 
PC + Bi2O3 -8.0600(*) .001 -12.4018 -3.7182 
MTA 
  
  
  
CONTROL 8.5833(*) .001 4.2415 12.9252 
PC + CHI3 .5667 .992 -3.7752 4.9085 
PC +ZrO2 3.4033 .148 -.9385 7.7452 
PC + Bi2O3 .5233 .994 -3.8185 4.8652 
 CONTROL MTA PC + CHI3 PC + ZrO2 PC+Bi2O3 
DAY 3 25.37 +/ - 1.02 33.71 +/ - 1.5 35.73 +/ - 0.56 32.76 +/ - 1.52 35.25 +/ - 3.87 
DAY 7 55.33 +/ - 1 63.91 +/ - 2.02 63.35 +/ - 1.1 60.51 +/ - 1.71 63.39 +/ - 1.94 
DAY 15 60.27 +/ -  1.72 75.81 +/ - 3.38 76.18 +/ - 1.95 73.19 +/ - 2.15 75.35 +/ - 0.81 
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DAY15 
  
  
  
CONTROL 
  
  
  
 
MTA 
  
  
  
MTA 
PC + CHI3 
PC +ZrO2 
PC + Bi2O3 
 
CONTROL 
PC + CHI3 
PC +ZrO2 
PC + Bi2O3 
-15.5400(*) 
-15.9067(*) 
-12.9233(*) 
-15.0833(*) 
 
15.5400(*) 
-.3667 
2.6167 
.4567 
.000 
.000 
.000 
.000 
 
.000 
1.000 
.598 
.999 
-21.3716 
-21.7383 
-18.7550 
-20.9150 
 
9.7084 
-6.1983 
-3.2150 
-5.3750 
-9.7084 
-10.0750 
-7.0917 
-9.2517 
 
21.3716 
5.4650 
8.4483 
6.2883 
 
* The mean difference is significant at the .05 level. 
 
Interpretation:  
The mean +/- SD of all OD values for ALP assay at 0.02 mg/ml concentration of 
the experimental sample was obtained and stastical analysis was performed. The 
results were as follows, 
· There was a significant difference between the control groups and all the 
experimental groups (p<0.01) at day 3, day 7 and day 15. 
· There was no statistically significant difference between the experimental 
groups at day 3, day 7 and day 15. 
· The OD values in ALP assay was significantly increased from day 3 to day 
15 (p<0.01) for all the experimental groups. 
 
 
 
 
 
 
 
Results 
 
42 
 
 
Chart-1 : Cytotoxicity of Mouse osteoblast cell lines (MC3T3-E1) at 24, 48 and 72 
hrs 
 
 
Chart-2 : ALP assay of Mouse osteoblast cell lines (MC3T3-E1) at 3, 7 and 15 days 
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III.qRT-PCR ANALYSIS 
 
a) Mineralization associated proteins 
i)  BSP 
Table 8 : Mean +/-  SD of OD values expressing mRNA of BSP  
 
Table 9 : Oneway ANOVA 
  
  Sum of 
Squares 
df Mean 
Square 
F Sig. 
HRS24 Between Groups 6804.620 4 1701.155 790.
544 
.000 
Within Groups 21.519 10 2.152   
Total 6826.138 14    
HRS48 Between Groups 1539.231 4 384.808 166.
992 
.000 
Within Groups 23.043 10 2.304   
Total 1562.274 14    
HRS72 Between Groups 8.092 4 2.023 .761 .574 
Within Groups 26.583 10 2.658   
Total 34.676 14    
 
Table 10 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
 CONTROL MTA PC + CHI 3 PC + ZrO2 PC + Bi2O3 
24 HRS 87.03 + / - 0.2 33.1 + / - 1.7 34.38 + / - 2.3 33.81 + / - 0.68 33.89 + / - 1.2 
48 HRS 86.46 + / - 1.3 60.8 + / - 2.1 60.73 + / - 1.3 61.32 + / - 1.07 61.66 + / - 1.6 
72 HRS 85.79 + / - 1.8 83.8 + / - 2.1 83.7 + / - 1.35 84.32 + / - 1.07 84.66 + / - 1.6 
Dependent 
Variable 
  
(I) 
GROUPS 
  
(J) 
GROUPS 
  
Mean Difference (I-
J) 
  
Sig. 
  
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
HRS24 
  
  
  
  
  
  
  
 
 
 
control 
  
  
  
MTA 53.9267(*) .000 49.9848 57.8685 
PC + CHI3 52.6567(*) .000 48.7148 56.5985 
PC + ZrO2 53.2233(*) .000 49.2815 57.1652 
PC + Bi2O3 53.1433(*) .000 49.2015 57.0852 
MTA 
  
  
  
control -53.9267(*) .000 -57.8685 -49.9848 
PC + CHI3 -1.2700 .822 -5.2119 2.6719 
PC + ZrO2 -.7033 .974 -4.6452 3.2385 
PC + Bi2O3 -.7833 .962 -4.7252 3.1585 
HRS48 
  
  
  
  
  
  
  
  
control 
  
  
  
MTA 25.5767(*) .000 21.4975 29.6558 
PC + CHI3 25.7267(*) .000 21.6475 29.8058 
PC + ZrO2 25.1433(*) .000 21.0642 29.2225 
PC + Bi2O3 24.8000(*) .000 20.7209 28.8791 
MTA 
  
  
  
  
control -25.5767(*) .000 -29.6558 -21.4975 
PC + CHI3 .1500 1.000 -3.9291 4.2291 
PC + ZrO2 -.4333 .996 -4.5125 3.6458 
PC + Bi2O3 -.7767 .967 -4.8558 3.3025 
PC + ZrO2 .3433 .998 -3.7358 4.4225 
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ii) OPN 
Table 11: Mean +/-  SD of OD values expressing mRNA of OPN values 
 
Table 12 : Oneway ANOVA 
 
    Sum of Squares df Mean Square F Sig. 
HRS24 
  
  
Between Groups 2684.428 4 671.107 248.834 .000 
Within Groups 26.970 10 2.697     
Total 2711.398 14       
HRS48 
  
  
Between Groups 1091.647 4 272.912 118.433 .000 
Within Groups 23.043 10 2.304     
Total 1114.690 14       
HRS72 
  
  
Between Groups 47.116 4 11.779 4.431 .026 
Within Groups 26.583 10 2.658     
Total 73.700 14       
 
Table 13 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
Dependent 
Variable 
(I) 
GROUPS 
(J) 
GROUPS 
Mean Difference (I-
J) 
Sig. 95% Confidence Interval 
          Lower 
Bound 
Upper 
Bound 
HRS24 
  
  
  
  
  
  
  
control MTA 31.6467(*) .000 27.2337 36.0597 
  PC + CHI3 35.5200(*) .000 31.1070 39.9330 
  PC + ZrO2 33.1600(*) .000 28.7470 37.5730 
  PC + Bi2O3 32.8600(*) .000 28.4470 37.2730 
MTA control -31.6467(*) .000 -36.0597 -27.2337 
  PC + CHI3 3.8733 .093 -.5397 8.2863 
  PC + ZrO2 1.5133 .789 -2.8997 5.9263 
  PC + Bi2O3 1.2133 .889 -3.1997 5.6263 
HRS48 
  
  
  
  
  
  
  
control MTA 21.5767(*) .000 17.4975 25.6558 
  PC + CHI3 21.7267(*) .000 17.6475 25.8058 
  PC + ZrO2 21.1433(*) .000 17.0642 25.2225 
  PC + Bi2O3 20.8000(*) .000 16.7209 24.8791 
MTA control -21.5767(*) .000 -25.6558 -17.4975 
  PC + CHI3 .1500 1.000 -3.9291 4.2291 
  PC + ZrO2 -.4333 .996 -4.5125 3.6458 
  PC + Bi2O3 -.7767 .967 -4.8558 3.3025 
HRS72 
  
  
  
control 
  
  
  
MTA 1.9100 .621 -2.4713 6.2913 
PC + CHI3 2.0600 .558 -2.3213 6.4413 
PC + ZrO2 1.4767 .798 -2.9046 5.8579 
PC + Bi2O3 1.1333 .908 -3.2479 5.5146 
 CONTROL MTA PC + CHI 3 PC + ZrO2 PC + Bi2O3 
24 HRS 87.03 + / - 0.22 55.39 + / - 0.96 51.51 + / - 0.57 53.87 + / - 2.5 54.17 + / - 2.3 
48 HRS 86.46 + / - 1.31 64.88 + / - 2.01 64.73 + / - 1.35 65.32 + / - 1.1 65.66 + / - 1.6 
72 HRS 85.79 + / - 1.87 89.88 + / - 2.01 89.73 + / - 1.35 90.32 + / - 1.2 90.66 + / - 1.6 
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HRS72 
  
  
  
control MTA -4.0900(*) .040 -8.4713 .2913 
  PC + CHI3 -3.9400(*) .043 -8.3213 .4413 
  PC + ZrO2 -4.5233(*) .042 -8.9046 -.1421 
  PC + Bi2O3 -4.8667(*) .028 -9.2479 -.4854 
 
iii) OCN 
Table 14 : Mean +/-  SD of of OD values expressing mRNA of OCN values 
 
Table 15 : Oneway ANOVA 
 
  
    Sum of 
Squares 
df Mean Square F Sig. 
HRS24 Between 
Groups 
3243.334 4 810.834 149.600 .000 
Within Groups 54.200 10 5.420     
Total 3297.534 14       
HRS48 Between 
Groups 
1305.839 4 326.460 141.671 .000 
Within Groups 23.043 10 2.304     
Total 1328.882 14       
HRS72 Between 
Groups 
10.015 4 2.504 1.292 .337 
Within Groups 19.383 10 1.938     
Total 29.398 14       
 
Table 16 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
Dependent 
Variable 
(I) 
GROUPS 
(J) 
GROUPS 
Mean Difference (I-
J) 
Sig. 95% Confidence Interval 
     Lower 
Bound 
Upper 
Bound 
HRS24 
 
 
 
 
 
 
 
control MTA 37.4600(*) .000 31.2040 43.7160 
 PC + CHI3 38.2133(*) .000 31.9574 44.4693 
 PC + ZrO2 35.2333(*) .000 28.9774 41.4893 
 PC + Bi2O3 35.7333(*) .000 29.4774 41.9893 
MTA control -37.4600(*) .000 -43.7160 -31.2040 
 PC + CHI3 .7533 .994 -5.5026 7.0093 
 PC + ZrO2 -2.2267 .767 -8.4826 4.0293 
 PC + Bi2O3 -1.7267 .887 -7.9826 4.5293 
HRS48 
 
 
 
 
 
control MTA 23.5767(*) .000 19.4975 27.6558 
 PC + CHI3 23.7267(*) .000 19.6475 27.8058 
 PC + ZrO2 23.1433(*) .000 19.0642 27.2225 
 PC + Bi2O3 22.8000(*) .000 18.7209 26.8791 
 CONTROL MTA PC + CHI 3 PC + ZrO2 Pc + Bi2O3 
24 HRS 87.03  +/- 0.22 49.57 +/- 2.13 48.82+/- 4.08 51.80 +/- 1.23 51.30 +/- 2.063 
48 HRS 86.46 +/- 1.31 62.88 +/- 2.01 62.73+/- 1.35 63.32 +/- 1.07 63.66 +/- 1.66 
72 HRS 85.79 +/- 1.87 84.88 +/- 2.01 84.73/- 1.35 85.32 +/- 1.07 85.66 +/- 1.66 
Results 
 
46 
 
 
 
MTA control -23.5767(*) .000 -27.6558 -19.4975 
 PC + CHI3 .1500 1.000 -3.9291 4.2291 
 PC + ZrO2 -.4333 .996 -4.5125 3.6458 
 PC + Bi2O3 -.7767 .967 -4.8558 3.3025 
HRS72 
 
 
 
control MTA 2.2433 .343 -1.4978 5.9845 
 PC + CHI3 1.0600 .878 -2.6812 4.8012 
 PC + ZrO2 .4767 .992 -3.2645 4.2178 
 PC + Bi2O3 .1333 1.000 -3.6078 3.8745 
 
iv) COL I 
 
Table 17 : Mean +/-  SD of  OD values expressing mRNA of COL I values 
 
Table 18 : Oneway  ANOVA 
 
    Sum of 
Squares 
df Mean Square F Sig. 
HRS24 Between 
Groups 
9771.639 4 2442.910 2850.714 .000 
Within Groups 8.569 10 .857     
Total 9780.208 14       
HRS48 Between 
Groups 
4503.759 4 1125.940 488.616 .000 
Within Groups 23.043 10 2.304     
Total 4526.802 14       
HRS72 Between 
Groups 
17.934 4 4.483 1.519 .269 
Within Groups 29.510 10 2.951     
Total 47.444 14       
 
Table 19 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
 
Dependent 
Variable 
(I) 
GROUPS 
(J) 
GROUPS 
Mean Difference (I-
J) 
Sig. 95% Confidence Interval 
          Lower 
Bound 
Upper 
Bound 
HRS24 
  
  
  
  
  
  
  
control MTA 63.9867(*) .000 61.4991 66.4742 
  PC + CHI3 64.4400(*) .000 61.9525 66.9275 
  PC + ZrO2 63.1933(*) .000 60.7058 65.6809 
  PC + Bi2O3 63.5800(*) .000 61.0925 66.0675 
MTA control -63.9867(*) .000 -66.4742 -61.4991 
  PC + CHI3 .4533 .972 -2.0342 2.9409 
  PC + ZrO2 -.7933 .827 -3.2809 1.6942 
  PC + Bi2O3 -.4067 .981 -2.8942 2.0809 
HRS48 
  
control MTA 43.5767(*) .000 39.4975 47.6558 
  PC + CHI3 43.7267(*) .000 39.6475 47.8058 
 CONTROL MTA PC + CHI 3 PC + ZrO2 Pc + Bi2O3 
24 HRS  87.03 + / - 0.22 23.05 + / - 1.34 22.59+ / - 0.83 23.84 + / - 0.11 23.45 + / - 1.31 
48 HRS 86.46 + / - 1.31 42.88 + / - 2.01 42.73+ / - 1.35 43.32 + / - 1.07 43.66 + / - 1.66 
72 HRS 
85.79 + / - 1.87 82.88+ / - 2.01 82.73+ / - 1.35 83.65 + / - 1.61 83.66 + / - 1.66 
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  PC + ZrO2 43.1433(*) .000 39.0642 47.2225 
  PC + Bi2O3 42.8000(*) .000 38.7209 46.8791 
MTA control -43.5767(*) .000 -47.6558 -39.4975 
  PC + CHI3 .1500 1.000 -3.9291 4.2291 
  PC + ZrO2 -.4333 .996 -4.5125 3.6458 
  PC + Bi2O3 -.7767 .967 -4.8558 3.3025 
  PC + ZrO2 .3433 .998 -3.7358 4.4225 
HRS72 
  
  
  
control MTA 2.9100 .301 -1.7061 7.5261 
  PC + CHI3 3.0600 .261 -1.5561 7.6761 
  PC + ZrO2 2.1433 .569 -2.4728 6.7595 
  PC + Bi2O3 2.1333 .573 -2.4828 6.7495 
 
Interpretation of Results obtained for Mineralization proteins: 
The mean +/- SD of all OD values relative to GADPHwas obtained and stastical 
analysis was performed. The results were as follows, 
i) BSP 
· The BSP expression level declined in both MTA and other 
experimental groups compared with the control group on the 
first and second day. (p<0.01) 
· However, gene expression recovered to the control level in 
both MTA and other experimental groups on the third day. 
.(p=0.574) 
· The gene expression between the experimental groups was 
statistically insignificant. 
ii) OPN 
· The OPN expression levels in the MTA and other experimental 
groups decreased significantly compared with the control 
group on the first day and second day. (p<0.01) 
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· By the third day, OPN expression was significantly enhanced 
in both MTA and other experimental groups compared with the 
control groups.(p=0.026) 
· The gene expression between the experimental groups was 
statistically insignificant. 
iii) OCN 
· The OCN expression levels declined in both MTA and other 
experimental groups compared with the control group on the 
first and second day. (p<0.01) 
· However, gene expression recovered to the control level in 
both MTA and other experimental groups on the third day. 
(p=0.337) 
· The gene expression between the experimental groups was 
statistically insignificant. 
iv) COL I 
· The COL I expression levels declined in both MTA and other 
experimental groups compared with the control group on the 
first and second day. . (p<0.01) 
· However, gene expression recovered to the control level in 
both MTA and other experimental groups on the third day. 
(p=0.269). 
· The gene expression between the experimental groups was 
statistically insignificant. 
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Chart-3 : mRNA expression of Mineralization associated proteins BSP & OPN 
analyzed by qRT-PCR  at 24, 48 and 72 hrs. 
 
Chart-4 : mRNA expression of Mineralization associated proteins OCN & COL I 
analyzed by qRT-PCR  at 24, 48 and 72 hrs. 
 
 
 
mRNA expression of Mineralization associated proteins by  qRT-PCR analysis at 
24, 48 and 72 hrs. GAPDH was used as housekeeping gene. 
 
 
  
                    24 hrs                        48 hrs 
 
 
 
                                                          72 hrs 
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a) Cytokines involved in Mineralization 
 
· 24 hrs 
 
Table 20 : Mean +/- SD of OD values expressing mRNA of cytokines at 24 HRS 
 CONTROL MTA PC + CHI3 PC + 
ZrO2 
PC+Bi2O3 
TNF α 43.69 +/- 1.78 34.6+/- 1.76 34.89 +/- 0.7 34.3 +/- 0.7 34.4+/- 0.66 
IL-6 54.48 +/- 1.28 47.03 +/- 0.22 46.93 +/- 0.9 47.5+/- 1.2 46.87+/- 0.6 
IL-1 α 18.66 +/- 0.3 3.34+/- 0.19 3.59+/- 0.41 3.51+/- 0.3 3.55+/- 0.37 
 
Table 21 : Oneway ANOVA 
 
  Sum of Squares df Mean Square F Sig. 
TNF α Between Groups 200.311 4 50.078 31.655 .010 
Within Groups 15.820 10 1.582   
Total 216.131 14    
IL-6 Between Groups 132.180 4 33.045 35.502 .010 
Within Groups 9.308 10 .931   
Total 141.487 14    
IL-1 α Between Groups 552.060 4 138.015 1217.850 .000 
Within Groups 1.133 10 .113   
Total 553.193 14    
 
Table 22 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
Dependent 
Variable 
(I) 
GROUPS 
(J) 
GROUPS 
Mean 
Difference (I-J) 
Sig. 95% Confidence 
Interval 
  
TNF α 
  
  
  
  
  
  
  
        Lower 
Bound 
Upper 
Bound 
CONTROL MTA 9.0967(*) .000 5.7168 12.4765 
  PC + CHI3 8.8067(*) .000 5.4268 12.1865 
  PC + ZrO2 9.3633(*) .000 5.9835 12.7432 
  PC + Bi2O3 9.2300(*) .000 5.8502 12.6098 
MTA CONTROL -9.0967(*) .000 -12.4765 -5.7168 
  PC + CHI3 -.2900 .998 -3.6698 3.0898 
  PC + ZrO2 .2667 .999 -3.1132 3.6465 
  PC + Bi2O3 .1333 1.000 -3.2465 3.5132 
IL-6 
  
  
  
  
  
  
  
CONTROL MTA 7.4500(*) .000 4.8575 10.0425 
  PC + CHI3 7.5567(*) .000 4.9642 10.1492 
  PC + ZrO2 6.9867(*) .000 4.3942 9.5792 
  PC + Bi2O3 7.6100(*) .000 5.0175 10.2025 
MTA CONTROL -7.4500(*) .000 -10.0425 -4.8575 
  PC + CHI3 .1067 1.000 -2.4858 2.6992 
  PC + ZrO2 -.4633 .974 -3.0558 2.1292 
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  PC + Bi2O3 .1600 1.000 -2.4325 2.7525 
IL-1 α 
  
  
  
  
  
  
  
CONTROL MTA 15.3267(*) .000 14.4221 16.2313 
  PC + CHI3 15.0700(*) .000 14.1654 15.9746 
  PC + ZrO2 15.1500(*) .000 14.2454 16.0546 
  PC + Bi2O3 15.1133(*) .000 14.2087 16.0179 
MTA CONTROL -15.3267(*) .000 -16.2313 -14.4221 
  PC + CHI3 -.2567 .877 -1.1613 .6479 
  PC + ZrO2 -.1767 .964 -1.0813 .7279 
  PC + Bi2O3 -.2133 .932 -1.1179 .6913 
 
· 48 hrs 
 
Table 23 : Mean +/- SD of OD values expressing mRNA of cytokines at 48 HRS 
 
 CONTROL MTA PC + 
CHI3 
PC + ZrO2 PC+Bi2O3 
TNF α 76.21 +/- 2.44 54.6 +/- 1.7 54.89 +/- 0.7 54.33 +/- 0.7 54.46 +/- 0.6 
IL-6 65.05 +/- 1.60 67.03 +/- 0.2 66.93 +/- 0.9 67.5 +/- 1.26 66.87 +/- 0.6 
IL-1 α 9.50 +/- 0.25 2.34 +/- 0.1 2.59 +/- 0.41 2.51 +/- 0.34 2.55 +/- 0.37 
 
Table 24 : Oneway ANOVA 
 
    Sum of Squares df Mean Square F Sig. 
TNF α 
  
  
Between Groups 1124.838 4 281.209 131.288 .010 
Within Groups 21.419 10 2.142     
Total 1146.257 14       
IL-6 
  
  
Between Groups 10.640 4 2.660 2.380 .121 
Within Groups 11.179 10 1.118     
Total 21.819 14       
IL-1 α 
  
  
Between Groups 2.538 4 .635 5.887 .001 
Within Groups 1.078 10 .108     
Total 3.616 14       
      
 
Table 25 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
 
Dependent 
Variable 
  
 
(I) GROUPS 
  
(J) GROUPS 
  
Mean 
Difference (I-J) 
  
Sig. 
  
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
  
 TNF α 
 
  
  
  
  
CONTROL 
  
  
  
MTA 21.6167(*) .000 17.6839 25.5494 
PC + CHI3 21.3267(*) .000 17.3939 25.2594 
PC + ZrO2 21.8833(*) .000 17.9506 25.8161 
PC + Bi2O3 21.7500(*) .000 17.8173 25.6827 
MTA 
  
CONTROL -21.6167(*) .000 -25.5494 -17.6839 
PC + CHI3 -.2900 .999 -4.2227 3.6427 
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PC + ZrO2 .2667 .999 -3.6661 4.1994 
PC + Bi2O3 .1333 1.000 -3.7994 4.0661 
IL-6 
  
  
  
CONTROL 
  
  
  
MTA -1.9833 .222 -4.8245 .8578 
PC + CHI3 -1.8767 .264 -4.7178 .9645 
PC + ZrO2 -2.4467 .101 -5.2878 .3945 
PC + Bi2O3 -1.8233 .286 -4.6645 1.0178 
IL-1 α 
  
  
  
  
  
  
  
CONTROL 
  
  
  
MTA 1.1667(*) .010 .2844 2.0489 
PC + CHI3 .9100(*) .043 .0278 1.7922 
PC + ZrO2 .9900(*) .027 .1078 1.8722 
PC + Bi2O3 .9533(*) .033 .0711 1.8356 
MTA 
  
  
  
CONTROL -1.1667(*) .010 -2.0489 -.2844 
PC + CHI3 -.2567 .868 -1.1389 .6256 
PC + ZrO2 -.1767 .961 -1.0589 .7056 
PC + Bi2O3 -.2133 .926 -1.0956 .6689 
 
· 72 hrs 
 
Table 26 : Mean +/- SD of OD values expressing mRNA of cytokines at 72 HRS 
 CONTROL MTA PC + CHI3 PC + ZrO2 PC+Bi2O3 
TNF α 86.28 +/- 1.77 74.6 +/- 1.7 74.89+/- 0.7 74.33+/- 0.7 74.46+/- 0.66 
IL-6 74.39+/- 1.22 87.03+/- 0.22 86.93+/- 0.9 87.5+/- 1.26 86.87+/- 0.61 
IL-1 α 6.29+/- 0.15 1.34+/- 0.19 1.59+/- 0.41 1.51+/- 0.34 1.55+/- 0.37 
 
Table 27 : Oneway ANOVA 
 
    Sum of 
Squares 
Df Mean Square F Sig. 
TNF α 
  
  
Between Groups 329.842 4 82.460 52.188 .010 
Within Groups 15.801 10 1.580   
Total 345.643 14    
IL-6 
  
  
Between Groups 387.365 4 96.841 107.709 .010 
Within Groups 8.991 10 .899   
Total 396.356 14    
IL-1 α 
  
  
Between Groups 55.218 4 13.805 138.619 .000 
Within Groups .996 10 .100   
Total 56.214 14    
      
 
 
Table 28 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
Dependent 
Variable 
  
(I) GROUPS 
  
(J) GROUPS 
  
Mean 
Difference (I-
J) 
  
Sig. 
  
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
TNF α  
  
CONTROL 
  
MTA 11.6867(*) .000 8.3089 15.0644 
PC + CHI3 11.3967(*) .000 8.0189 14.7744 
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PC + ZrO2 11.9533(*) .000 8.5756 15.3311 
PC + Bi2O3 11.8200(*) .000 8.4422 15.1978 
MTA 
  
  
  
CONTROL -11.6867(*) .000 -15.0644 -8.3089 
PC + CHI3 -.2900 .998 -3.6678 3.0878 
PC + ZrO2 .2667 .999 -3.1111 3.6444 
PC + Bi2O3 .1333 1.000 -3.2444 3.5111 
IL-6 
  
  
  
  
  
  
  
CONTROL 
  
  
  
MTA -12.6433(*) .000 -15.1913 -10.0953 
PC + CHI3 -12.5367(*) .000 -15.0847 -9.9887 
PC + ZrO2 -13.1067(*) .000 -15.6547 -10.5587 
PC + Bi2O3 -12.4833(*) .000 -15.0313 -9.9353 
MTA 
  
  
  
CONTROL 12.6433(*) .000 10.0953 15.1913 
PC + CHI3 .1067 1.000 -2.4413 2.6547 
PC + ZrO2 -.4633 .972 -3.0113 2.0847 
PC + Bi2O3 .1600 1.000 -2.3880 2.7080 
IL-1 α 
  
  
  
  
  
  
  
CONTROL 
  
  
  
MTA 4.9533(*) .000 4.1053 5.8013 
PC + CHI3 4.6967(*) .000 3.8487 5.5447 
PC + ZrO2 4.7767(*) .000 3.9287 5.6247 
PC + Bi2O3 4.7400(*) .000 3.8920 5.5880 
MTA 
  
  
  
CONTROL -4.9533(*) .000 -5.8013 -4.1053 
PC + CHI3 -.2567 .851 -1.1047 .5913 
PC + ZrO2 -.1767 .955 -1.0247 .6713 
PC + Bi2O3 -.2133 .916 -1.0613 .6347 
 
Interpretation  
The mean +/- SD of all OD values relative to GADPH was obtained and 
stastical analysis was performed. The results were as follows, 
At 24 hrs, 
· The qRT-PCR analysis detected moderate to high levels of IL-6 and TNF 
alpha on all the groups but significantly less than the control group (p<0.01).  
· IL-1alpha was more detected in control group and its reduction in the 
presence of experimental groups was highly significant (p=0). 
· The expression of all cytokines between the experimental groups was 
statistically insignificant. 
At 48 hrs, 
· The qRT-PCR analysis detected moderate to high levels of TNF alpha on all 
the groups but significantly less than the control group (p<0.01).  
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· IL-1alpha was more detected in control group and its reduction in the 
presence of experimental groups was highly significant (p=0). 
· At 48 hrs, the level of IL-6 in all the experimental groups was insignificant 
with the control group. (p=0.121). 
· The expression of all cytokines between the experimental groups was 
statistically insignificant. 
At 72 hrs, 
· The qRT-PCR analysis detected moderate to high levels of TNF alpha on all 
the groups but significantly less than the control group (p<0.01).  
· IL-1alpha was more detected in control group and its reduction in the 
presence of experimental groups was highly significant (p=0). 
· At 72 hrs, the level of IL-6 was increased significantly in all the 
experimental groups than the control group. (p=0.01). 
· The expression of all cytokines between the experimental groups was 
statistically insignificant. 
 
b) Cytokines involved in Mineralization (LPS stimulated) 
 
· 24 hrs 
Table 29 : Mean +/- SD of OD values expressing mRNA of cytokines at 24 HRS 
 CONTROL LPS alone LPS + MTA LPS +  PC 
+ CHI3 
LPS + PC + 
ZrO2 
LPS + 
PC+Bi2O3 
TNF α  43.69± 1.78 18.5± 0.53 33.81±0.68 33.89 ± 1.25 34.52± 0.53 35.57 ± 1.32 
IL-6 54.48± 1.28 23.88± 0.62 34.40± 1.17 34.38±1.25 35.12± 0.66 34.74± 0.41 
IL-1 α 18.66± 0.30 42.87± 1.64 8.7± 0.24 8.74 ± 0.07 8.77± 0.12 8.50± 0.54 
 
Table 30 : Oneway ANOVA 
 
  Sum of Squares df Mean Square F Sig. 
TNF α 
  
Between Groups 1003.168 5 200.634 159.94 .000 
Within Groups 15.053 12 1.254   
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  Total 1018.221 17    
IL-6 
  
  
Between Groups 1487.453 5 297.491 318.90 .000 
Within Groups 11.194 12 .933   
Total 1498.647 17    
IL-1 α 
  
  
Between Groups 2816.147 5 563.229 1169.9 .000 
Within Groups 5.777 12 .481   
Total 2821.924 17    
 
 
Table 31 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
Dependent 
Variable 
(I) 
GROUPS 
(J) GROUPS Mean 
Difference (I-
J) 
Sig. 95% Confidence Interval 
          Lower 
Bound 
Upper 
Bound 
TNF α 
  
  
  
  
  
  
CONTROL LPS ALONE 25.1967(*) .000 22.1250 28.2683 
  LPS + MTA 9.8833(*) .000 6.8117 12.9550 
  LPS + PC + CHI3 9.8033(*) .000 6.7317 12.8750 
  LPS+ PC + ZrO2 9.1733(*) .000 6.1017 12.2450 
  LPS + PC + Bi2O3 8.1267(*) .000 5.0550 11.1983 
LPS alone CONTROL -25.1967(*) .000 -28.2683 -22.1250 
  LPS + MTA -15.3133(*) .000 -18.3850 -12.2417 
  
  
  
  
  
  
  
  
  LPS + PC + CHI3 -15.3933(*) .000 -18.4650 -12.3217 
  LPS+ PC + ZrO2 -16.0233(*) .000 -19.0950 -12.9517 
  LPS + PC + Bi2O3 -17.0700(*) .000 -20.1417 -13.9983 
LPS + MTA CONTROL -9.8833(*) .000 -12.9550 -6.8117 
  LPS ALONE 15.3133(*) .000 12.2417 18.3850 
  LPS + PC + CHI3 -.0800 1.000 -3.1517 2.9917 
  LPS+ PC + ZrO2 -.7100 .967 -3.7817 2.3617 
  LPS + PC + Bi2O3 -1.7567 .435 -4.8283 1.3150 
IL-6 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
CONTROL LPS ALONE 30.6000(*) .000 27.9511 33.2489 
  LPS + MTA 20.0800(*) .000 17.4311 22.7289 
  LPS + PC + CHI3 20.1000(*) .000 17.4511 22.7489 
  LPS+ PC + ZrO2 19.3667(*) .000 16.7178 22.0155 
  LPS + PC + Bi2O3 19.7467(*) .000 17.0978 22.3955 
LPS alone CONTROL -30.6000(*) .000 -33.2489 -27.9511 
  LPS + MTA -10.5200(*) .000 -13.1689 -7.8711 
  LPS + PC + CHI3 -10.5000(*) .000 -13.1489 -7.8511 
  LPS+ PC + ZrO2 -11.2333(*) .000 -13.8822 -8.5845 
  LPS + PC + Bi2O3 -10.8533(*) .000 -13.5022 -8.2045 
LPS + MTA CONTROL -20.0800(*) .000 -22.7289 -17.4311 
  LPS ALONE 10.5200(*) .000 7.8711 13.1689 
  LPS + PC + CHI3 .0200 1.000 -2.6289 2.6689 
  LPS+ PC + ZrO2 -.7133 .938 -3.3622 1.9355 
  LPS + PC + Bi2O3 -.3333 .998 -2.9822 2.3155 
IL-1 α 
  
  
  
  
  
  
  
CONTROL LPS ALONE -24.2067(*) .000 -26.1096 -22.3038 
  LPS + MTA 9.9633(*) .000 8.0604 11.8662 
  LPS + PC + CHI3 9.9300(*) .000 8.0271 11.8329 
  LPS+ PC + ZrO2 9.8900(*) .000 7.9871 11.7929 
  LPS + PC + Bi2O3 9.8300(*) .000 7.9271 11.7329 
LPS alone CONTROL 24.2067(*) .000 22.3038 26.1096 
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  LPS + MTA 34.1700(*) .000 32.2671 36.0729 
  LPS + PC + CHI3 34.1367(*) .000 32.2338 36.0396 
  LPS+ PC + ZrO2 34.0967(*) .000 32.1938 35.9996 
  LPS + PC + Bi2O3 34.0367(*) .000 32.1338 35.9396 
LPS + MTA CONTROL -9.9633(*) .000 -11.8662 -8.0604 
  LPS ALONE -34.1700(*) .000 -36.0729 -32.2671 
  LPS + PC + CHI3 -.0333 1.000 -1.9362 1.8696 
  LPS+ PC + ZrO2 -.0733 1.000 -1.9762 1.8296 
  LPS + PC + Bi2O3 -.1333 1.000 -2.0362 1.7696 
 
· 48 hrs 
Table 32 : Mean +/- SD of OD values expressing mRNA of cytokines at 48 HRS 
 CONTROL LPS alone LPS + 
MTA 
LPS +  PC 
+ CHI3 
LPS + PC + 
ZrO2 
LPS + 
PC+Bi2O3 
TNF α 76.21+/- 2.4 13.07+/- 0.7 45.76+/- 2.2 45.62+/- 1.2 46.47+/- 1.9 46.26+/- 0.9 
IL-6 65.05+/- 1.6 17.31+/- 1.9 45.03+/- 3.2 46.58+/- 2.2 45.04+/- 0.3 46.70+/- 1.5 
IL-1 α 3.50+/- 0.2 41.28+/- 1.7 2.37+/- 0.1 2.41+/- 0.1 2.14+/- 0.4 1.99+/- 0.4 
 
Table 33 : Oneway ANOVA 
 
    Sum of Squares df Mean Square F Sig. 
TNF α 
  
  
Between Groups 5989.134 5 1197.827 501.848 .000 
Within Groups 28.642 12 2.387     
Total 6017.776 17       
IL-6 
  
  
Between Groups 3512.656 5 702.531 180.544 .000 
Within Groups 46.694 12 3.891     
Total 3559.350 17       
IL-1 α 
  
  
Between Groups 3767.974 5 753.595 1230.917 .000 
Within Groups 7.347 12 .612     
Total 3775.321 17       
 
Table 34 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
Dependent 
Variable 
(I) GROUPS (J) GROUPS Mean 
Difference 
(I-J) 
Sig. 95% Confidence Interval 
          Lower 
Bound 
Upper 
Bound 
TNF α 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
CONTROL LPS ALONE 63.1400(*) .000 58.9029 67.3771 
  LPS + MTA 30.4500(*) .000 26.2129 34.6871 
  LPS + PC + CHI3 30.5900(*) .000 26.3529 34.8271 
  LPS+ PC + ZrO2 29.7433(*) .000 25.5063 33.9804 
  LPS + PC + Bi2O3 29.9500(*) .000 25.7129 34.1871 
LPS ALONE CONTROL -63.140(*) .000 -67.3771 -58.9029 
  LPS + MTA -32.690(*) .000 -36.9271 -28.4529 
  LPS + PC + CHI3 -32.550(*) .000 -36.7871 -28.3129 
  LPS+ PC + ZrO2 -33.396(*) .000 -37.6337 -29.1596 
  LPS + PC + Bi2O3 -33.190(*) .000 -37.4271 -28.9529 
LPS + MTA CONTROL -30.450(*) .000 -34.6871 -26.2129 
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  LPS ALONE 32.6900(*) .000 28.4529 36.9271 
  LPS + PC + CHI3 .1400 1.00 -4.0971 4.3771 
  LPS+ PC + ZrO2 -.7067 .992 -4.9437 3.5304 
  LPS + PC + Bi2O3 -.5000 .998 -4.7371 3.7371 
IL-6 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
CONTROL LPS ALONE 47.7367(*) .000 42.3267 53.1466 
  LPS + MTA 20.0200(*) .000 14.6100 25.4300 
  LPS + PC + CHI3 18.4700(*) .000 13.0600 23.8800 
  LPS+ PC + ZrO2 20.0067(*) .000 14.5967 25.4166 
  LPS + PC + Bi2O3 18.3500(*) .000 12.9400 23.7600 
LPS ALONE CONTROL -47.736(*) .000 -53.1466 -42.3267 
  LPS + MTA -27.716(*) .000 -33.1266 -22.3067 
  LPS + PC + CHI3 -29.266(*) .000 -34.6766 -23.8567 
  LPS+ PC + ZrO2 -27.730(*) .000 -33.1400 -22.3200 
  LPS + PC + Bi2O3 -29.387(*) .000 -34.7966 -23.9767 
LPS + MTA CONTROL -20.020(*) .000 -25.4300 -14.6100 
  LPS ALONE 27.7167(*) .000 22.3067 33.1266 
  LPS + PC + CHI3 -1.5500 .921 -6.9600 3.8600 
  LPS+ PC + ZrO2 -.0133 1.00 -5.4233 5.3966 
  LPS + PC + Bi2O3 -1.6700 .896 -7.0800 3.7400 
IL-1 α 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
CONTROL LPS ALONE -37.780(*) .000 -39.9259 -35.6341 
  LPS + MTA 1.1300 .517 -1.0159 3.2759 
  LPS + PC + CHI3 1.0900 .553 -1.0559 3.2359 
  LPS+ PC + ZrO2 1.3667 .331 -.7792 3.5126 
  LPS + PC + Bi2O3 1.5160 .239 -.6299 3.6619 
LPS ALONE CONTROL 37.7800(*) .000 35.6341 39.9259 
  LPS + MTA 38.9100(*) .000 36.7641 41.0559 
  LPS + PC + CHI3 38.8700(*) .000 36.7241 41.0159 
  LPS+ PC + ZrO2 39.1467(*) .000 37.0008 41.2926 
  LPS + PC + Bi2O3 39.2960(*) .000 37.1501 41.4419 
LPS + MTA CONTROL -1.1300 .517 -3.2759 1.0159 
  LPS ALONE -38.910(*) .000 -41.0559 -36.7641 
  LPS + PC + CHI3 -.0400 1.00 -2.1859 2.1059 
  LPS+ PC + ZrO2 .2367 .999 -1.9092 2.3826 
  LPS + PC + Bi2O3 .3860 .989 -1.7599 2.5319 
 
· 72 hrs 
 
Table 35 : Mean +/- SD of OD values expressing mRNA of cytokines at 72 HRS 
 CONTROL LPS alone LPS + 
MTA 
LPS +  PC 
+ CHI3 
LPS + PC + 
ZrO2 
LPS + 
PC+Bi2O3 
TNF α 86.28+/- 1.7 8.29+/- 0.5 66.68+/- 1.1 66.69+/- 1.1 65.95+/-3.19 65.99+/- 4.5 
IL-6 74.39+/- 1.22 14.88+/- 0.4 64.39+/-1.2 64.52+/- 0.5 65+/- 0.13 65+/- 0.41 
IL-1 α 1.29+/- 0.15 51.54+/- 0.8 1.40+/- 0.27 1.4+/- 0.1 1.48+/- 0.28 1.13+/- 0.61 
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Table 36 : Oneway ANOVA 
 
    Sum of Squares df Mean Square F Sig. 
TNF α 
  
  
Between 
Groups 
10576.955 5 2115.391 345.560 .000 
Within Groups 73.460 12 6.122     
Total 10650.414 17       
IL-6 
  
  
Between 
Groups 
6938.810 5 1387.762 2249.27 .000 
Within Groups 7.404 12 .617     
Total 6946.213 17       
IL-1 α 
  
  
Between 
Groups 
6299.477 5 1259.895 5941.50 .000 
Within Groups 2.545 12 .212     
Total 6302.021 17       
 
Table 37 : Post Hoc Tests - Multiple Comparisons -Tukey HSD 
 
Dependent 
Variable 
(I) GROUPS (J) GROUPS Mean 
Difference 
(I-J) 
Sig. 95% Confidence 
Interval 
          Lower 
Bound 
Upper 
Bound 
TNF α 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
CONTROL LPS ALONE 77.9967(*) .000 71.211 84.7823 
  LPS + MTA 19.6067(*) .000 12.821 26.3923 
  LPS + PC + CHI3 19.5967(*) .000 12.811 26.3823 
  LPS+ PC + ZrO2 20.3300(*) .000 13.544 27.1156 
  LPS + PC + Bi2O3 20.2967(*) .000 13.511 27.0823 
LPS alone CONTROL -77.996(*) .000 -84.78 -71.2111 
  LPS + MTA -58.390(*) .000 -65.17 -51.6044 
  LPS + PC + CHI3 -58.400(*) .000 -65.18 -51.6144 
  LPS+ PC + ZrO2 -57.666(*) .000 -64.45 -50.8811 
  LPS + PC + Bi2O3 -57.700(*) .000 -64.48 -50.9144 
LPS + MTA CONTROL -19.60(*) .000 -26.39 -12.82 
  LPS ALONE 58.3900(*) .000 51.60 65.1756 
  LPS + PC + CHI3 -.0100 1.00 -6.795 6.7756 
  LPS+ PC + ZrO2 .7233 .999 -6.06 7.5089 
  LPS + PC + Bi2O3 .6900 .999 -6.09 7.4756 
IL-6 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
CONTROL LPS ALONE 59.5133(*) .000 57.35 61.6676 
  LPS + MTA 9.9967(*) .000 7.8424 12.1509 
  LPS + PC + CHI3 9.8733(*) .000 7.7191 12.0276 
  LPS+ PC + ZrO2 9.1533(*) .000 6.9991 11.3076 
  LPS + PC + Bi2O3 9.3900(*) .000 7.2358 11.5442 
LPS alone CONTROL -59.513(*) .000 -61.66 -57.3591 
  LPS + MTA -49.516(*) .000 -51.67 -47.3624 
  LPS + PC + CHI3 -49.64(*) .000 -51.79 -47.4858 
  LPS+ PC + ZrO2 -50.36(*) .000 -52.52 -48.2058 
  LPS + PC + Bi2O3 -50.12(*) .000 -52.27 -47.9691 
LPS + MTA CONTROL -9.9967(*) .000 -12.15 -7.8424 
  LPS ALONE 49.5167(*) .000 47.36 51.6709 
  LPS + PC + CHI3 -.1233 1.00 -2.27 2.0309 
  LPS+ PC + ZrO2 -.8433 .772 -2.99 1.3109 
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  LPS + PC + Bi2O3 -.6067 .926 -2.76 1.5476 
  LPS + PC + CHI3 .7200 .863 -1.43 2.8742 
  LPS + PC + Bi2O3 .2367 .999 -1.91 2.3909 
IL-1 α 
  
  
  
  
  
   
  
  
   
  
  
  
CONTROL 
  
  
  
  
LPS ALONE -50.246(*) .000 -51.50 -48.9838 
LPS + MTA -.1133 1.00 -1.37 1.1496 
LPS + PC + CHI3 -.1067 1.00 -1.36 1.1562 
LPS+ PC + ZrO2 -.1867 .995 -1.44 1.0762 
LPS + PC + Bi2O3 .1567 .998 -1.10 1.4196 
LPS alone 
  
  
  
  
CONTROL 50.2467(*) .000 48.98 51.5096 
LPS + MTA 50.1333(*) .000 48.87 51.3962 
LPS + PC + CHI3 50.1400(*) .000 48.87 51.4029 
LPS+ PC + ZrO2 50.0600(*) .000 48.79 51.3229 
LPS + PC + Bi2O3 50.4033(*) .000 49.14 51.6662 
LPS + MTA 
  
  
  
  
CONTROL 0.1133 1.00 -1.14 1.3762 
LPS ALONE -50.133(*) .000 -51.39 -48.8704 
LPS + PC + CHI3 .0067 1.00 -1.25 1.2696 
LPS+ PC + ZrO2 -.0733 1.00 -1.33 1.1896 
LPS + PC + Bi2O3 .2700 .976 -.99 1.5329 
 
Interpretation  
The mean +/- SD of all OD values relative to GADPH was obtained and statistical 
analysis was performed. The results were as follows, 
At 24, 48 and 72 hrs, 
· Despite LPS stimulation, the qRT-PCR analysis detected moderate to high 
levels of IL-6 and TNF alpha on all the groups but significantly less than the 
control group (p<0.01).  
· IL-1alpha was more detected in control group and significantly increased in 
LPS alone group (p<0.01).   
· Despite LPS stimulation, in the presence of experimental material, IL-
1alpha expression was minimally detected or it was highly negligible (p=0). 
· The expression of all cytokines between the experimental groups was 
statistically insignificant. 
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Chart-5 : mRNA expression of cytokines analyzed by qRT-PCR  at 24, 48 and 72 
hrs. 
 
 
Chart-6 :  mRNA expression of cytokines (LPS stimulated) analyzed by qRT-PCR  
at 24, 48 and 72 hrs. 
 
 
 
mRNA expression of Cytokines involved in the Mineralization by  qRT-PCR 
analysis at 24, 48 and 72 hrs. GAPDH was used as housekeeping gene. 
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mRNA expression of Cytokines involved in the Mineralization (LPS Stimulated) 
by  qRT-PCR analysis at 24, 48 and 72 hrs. GAPDH was used as housekeeping 
gene. 
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The growing technology and continuous introduction of new materials for 
different endodontic applications make the evaluation of the biological properties a 
mandatory condition. Biocompatibility is the most important property of endodontic 
materials as because these endodontic materials will be in permanent contact with 
periapical tissues. Cells in the periapical tissues are mainly Osteoblasts, 
Cementoblasts and Periodontal ligament cells. Favorable responses to these cells must 
also be assessed for better evaluation of new endodontic material. Hence Endodontic 
materials used as furcal perforation repair, root end filling and as an apical plug must 
be investigated for biocompatibility and other favorable cellular responses to 
periapical tissues. In the present study we used Pro Root MTA (Dentsply,USA) and 
white Portland cement – Birla white (Grasim Ind ltd. Aditya Birla group) to compare 
the favorable cellular responses between them. 
 
Type I Portland cement was present as the main component of MTA. 
According to manufacturer, Pro Root MTA has 75% Portland cement, 20% Bismuth 
oxide and 5% dehydrated calcium sulphate.  MTA exhibits good in vivo biologic 
performance when used for root-end fillings, pulp capping and pulpotomy, perforation 
repairs and apexification treatment62, 61 MTA promotes biomineralization of 
osteoblasts and cementoblasts21 and enhance mineralization27. MTA primarily 
consists of calcium silicate, calcium aluminate, and calcium hydroxide. Ca2+ ions are 
released from hydrated MTA when MTA powder is mixed with sterile water. The 
amount of Ca2+ released has been shown to be adequate for osteoblast survival, 
proliferation and differentiation31. Portland cement is similar to MTA with the 
exception of radiopacifier, Bismuth oxide which is present only in MTA. Therefore, 
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calcium ion released from Portland cement may also play an important role in 
osteoblast cellular responses.   
 
 Portland cement is most widely used material in construction. Portland cement 
is manufactured by clinkering process or partial fusion of raw materials. This process 
includes lime stone decarbonisation at 400⁰ to 600. It forms dicalcium silicate, 
tricalcium silicate and tricalcium aluminoferrite between 800⁰ and 1200 ⁰c . The 
tricalcium silicate is formed at 1400⁰C by the reaction between dicalcium silicate and 
free lime. Portland cement is classified into different types, depending on the type of 
additives.57 White Portland cement (WPC)  which is a type I Portland cement contains 
lower iron content than ordinary Portland cement and therefore it is lighter in color 
and more esthetic9. 
 
  The chemical components were found to be similar in both Portland cement 
and Pro Root MTA and there was a small percentile difference. Despite their chemical 
similarity, difference in the particle texture and size were observed.  Pro Root MTA 
contains 9.2 percentage of bismuth oxide. The X-ray diffraction results showed  that 
tricalcium silicate, dicalcium silicate, tricalcium aluminate and tetracalcium 
aluminoferrite were the major constitutents of both WPC and Pro Root MTA25. The 
antimicrobial activity was similar in both MTA & WPC and this is due to elevated 
pH. Torabinejad found that an initial pH of 10.2 for MTA, rising to 12.5 in 3hr. The 
addition of a radiopacifying agent to Portland cement does not hinder its antimicrobial 
action34. The presence of metals like  arsenic in MTA and Portland cement was a 
major hindrance to their  use in medicine. According to ISO 9917-1 standard, water – 
based cements:  Powder/liquid acid base cements (2003), a material to be used in 
dental procedures should contain no more arsenic than 2 mg/kg of cement. The 
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concentration of arsenic in Pro Root MTA is 5.25 mg/kg and in white Portland 
cement is 0.5 mg/kg.  MTA is used in small amounts, less than a gram in clinical 
procedures. Hence 34.27 mg of arsenic per kg of ordinary Portland cement is equal to 
34.27µg of arsenic per gm, which is much below the lethal dose of 2 mg/kg of body 
weight8. 
 
  Lack of radiopacity was a major problem when considering the use of 
Portland cement as a substitute to Pro Root MTA. Hence Radiopacifying agents 
should be added to Portland cement. The ISO 6876/2001 standard reported  that root 
canal sealer should be  minimum 3 mm Al equivalent radiopaque. According to 
American National Standard Institute and American Dental Association Sp. No.57, 
endodontic filling material should present a radiopacity equivalent to 2mm Al in 
comparison to bone or dentin. Radiopacity of Pro Root MTA was 6.74 mmAl eq and 
WPC was 0.95 mmAl eq.  
 
 Marco Antonio (2009)32 tested the radiopacity of Portland cement with 
various radiopacifying agents: Bismuth oxide, Zinc oxide, Iodoform, , Lead oxide, 
Bismuth carbonate, Barium sulphate, Calcium tungstate and Zirconium oxide. A 
20%wt radiopacifiers were added with 80%wt Portland cement. Bismuth oxide, 
Zirconium dioxide and Iodoform when added with Portland cement had radiopacity 
values 5.93mmAl, 3.41mm Al and 4.24mmAl respectively. All values are well above 
the  recommended  value of ADA/ANSI.  In the present study Bismuth oxide, 
Iodoform and Zirconium dioxide as the radiopacifiers were mixed with the Portland 
cement. They were mixed with white Portland cement in the ratio of 4:1 (i.e.,  20wt% 
radiopacifying agents + 80wt% WPC).  Bismuth oxide was also used as one of the 
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radiopacifier, so that to compare the response of Portland cement + Bismuth oxide to 
that of MTA which also contains the same radiopacifier.  
 
 Coomarswamy et al (2007) in their study described the effects of bismuth 
oxide on MTA. He found that the addition of bismuth oxide will decrease the 
mechanical stability by introducing flaws and increased porosity because of leaving 
more unreacted water within the Portland cement. This will affect the longevity of the 
material14. Hence there was a need for an alternative radiopacifying agent. Hence we 
also included Iodoform and Zirconium dioxide as radiopacifying agents in the 
experimental groups. The Iodoform as a radiopaque agent is added to the WPC 
because of its good radiopacity, prompt availability and its antiseptic property.  
Zirconium oxide is added because of its extraordinary properties such as high flexural 
strength (1,000 MPa), hardness (1,200 – 1,400 VHN) and more esthetic appearance. 
 
The present study has shown that Portland cement with Radiopacifying agents 
and MTA were similar in terms of supporting a favorable cellular response. The 
cellular response to these materials has been the subject of investigation. Most of the 
studies used osteosarcoma cells which resemble osteoblasts. But these osteoblasts 
alter biological regulatory mechanisms which can lead to an aberrant response43. 
Therefore; other studies used rodent cell lines.56, 64. Here in this study we used clonal 
mouse pre-osteoblastic cell line (MC3T3-E1) because it has high level of 
differentiation and can express osteoblastic markers such as CbfA1/RunX2, alkaline 
phosphatase (AP), Bone Sialoprotein (BSP) osteopontin (OPN) and osteocalcin (OCN). 
Hence it is considered as an excellent model for cellular differentiation studies.  
 
Various methods were used to test biocompatibility of calcium based materials 
in osteoblastic cell lines. The sample preparation and methodology used were similar 
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to methodology used in study conducted by Sema S. Hakki et al. (2009). According 
to this method the ratio between the surface of the samples and the volume of medium 
should be 0.5 cm2/ml. But in this method, ISO standard (10993-5) was not used. 
Despite the fact that MTA and other experimental materials was not soluble in 
water59, bioactive components from experimental materials might release into 
surrounding medium and might affect the cellular response in the vicinity of the 
material. Thus, to determine the effects of factors released by experimental materials 
on the osteoblasts, a new approach for preparation of experimental materials was 
carried out in this method. Experimental materials powder was added to MEM 
containing 5% FCS. At a concentration of 10 mg/ml (10 mg MTA:1 ml MEM), the 
solution was vortexed until completely mixed and incubated for 24 hours (5% CO2, 
370C) to extract the bioactive content of the WMTA. Then this extract was used to 
find the toxicity of the experimental materials at 24, 48 and 72 hrs. 
 
MTA needs wet environment for initial chemical reaction. Hence this method 
would better mimic the clinical conditions. This technique is also more realistic than 
the other methodologies because the bioactive components will be released in a 
different quantity into the surrounding medium before or after setting.  Also, the 
difference in the released bioactive components will interact with surrounding tissues 
differently. 
  
Sema S. Hakki et al. (2009) reported that 20 mg/ml of experimental material 
was toxic to cells and hence 10 mg/ml was chosen as an initial concentration and was 
further diluted into 9 different concentrations. This was done to evaluate the best 
concentration of the experimental material sample with best cell survival ability and 
this concentration was used for ALP assay and qRT-PCR analysis. The results 
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obtained were consistent with results found by Sema S. Hakki et al. (2009) and 0.02 
mg/ml was the minimum dilution that was chosen as a best experimental material 
sample. 
 
MTT assay 
In the present study, Portland cement with three different radiopacifying 
agents had no cytotoxicity to MC3T3-E1 osteoblast cells, which was similar to that 
for MTA. MTT assay measures the metabolic activity of cells grown over the 
materials under study. Cell proliferation is determined using a redox indicator that can 
be used to quantitatively measure proliferation of cells. The cell proliferation and cell 
survival is due to release of Ca2+ ions from the experimental materials which maintain 
the cellular activity at high alkaline pH. In the present study, the cell viability with the 
presence of all experimental groups was decreased on the first day and second day but 
increased significantly on the third day compared to the control group. This was due 
to the initial high pH of the experimental material that inhibited the cell growth on the 
first and second day. The cell survival ability was statistically insignificant between 
the experimental groups. This suggests that the Portland cement can be used in place 
of MTA after addition of any radiopacifier. 
 
ALP assay 
This present study tested the ALP activity when experimental materials were 
in direct contact with osteoblast cells. Alkaline phosphatase activity is an important 
marker for osteoblastic activity. Lowry et al (1946) described the Alkaline 
phophatase assay. It was done by measuring p-nitrophenol spectrophotometrically. In 
the presence of alkaline pH, alkaline phosphatase act as an enzyme and can hydrolyze 
p-nitrophenyl phosphate to yellow colored product, p-nitrophenol. The initial high pH 
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of the materials and less nutrients may damage the cells and regeneration of cells. 
This causes reduced ALP activity in day 3. But there is increased osteoblastic 
differentiation and ALP activity in day 7 and day 15.  The osteoblastic differentiation 
and ALP activity was statistically insignificant between the experimental groups. 
Hence these materials can be used as root end filling especially in non-vital immature 
teeth which allows the affected tooth to be restored endodontically after achieving an 
apical plug. Beyond the apical plug, osteoinductive potential of these experimental 
materials promotes undisturbed formation of the calcific bridge. 
 
Mineralization associated proteins by qRT-PCR analysis 
In this study we evaluated the mRNA expression of mineralization associated 
proteins (BSP, OPN, OCN AND COL I) and cytokines involved in mineralization 
(TNF alpha, IL-6 and IL-1 alpha) using quantitative Reverse transcriptase polymerase 
chain reaction (qRT-PCR). qRT-PCR is the preferred technique to detect and quantify 
mRNA. The first step is the reverse transcription which synthesizes cDNA from 
RNA. The second step amplifies cDNA to the detectable levels. This method has been 
used in various studies,19,24,49 to detect mRNA expression of osteogenic and 
odontogenic markers in various cell lines. 
 
BSP, OPN, OCN and COL I are important proteins in mineralized connective 
tissues. The BSP gene codes for Bone sialoprotein, is highly specific for mineralized 
tissues like bone and cementum22. Highest BSP expression indicates newly 
synthesized and regenerated bone matrix. The COL1 gene codes for a collagenous 
protein which is the major component of the extracellular matrix of osteoblasts. 
Osteocalcin, coded by gene OCN, is a non collagenous protein expressed in the 
extracellular matrix during osteoblastic mineralization. Osteopontin, coded by gene 
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OPN, is an organic component of bone and plays an important role in extracellular 
matrix mineralization46. 
 
In the present study, we observed at 0.02 mg/ml of experimental materials 
there is increased induction of osteogenic gene expression (BSP, OPN, OCN, and 
COL I) from 24 to 72 hrs. The expression level of these four genes was lowest on the 
first day. It may be due to the pH changes of the experimental materials during 
setting. When experimental materials were mixed with sterile water, the pH of the 
medium increased from 7.2 to 12.5 within first 24 hours and this pH change may 
cause an inhibition on gene expression on day 158,54.  But these gene expressions 
substantially activated by experimental materials on the second day and third day. 
These gene expressions between the experimental materials were statistically 
insignificant. This indicates that MTA and Portland cement with radiopacifying 
agents can induce mineralization and mineralized tissue associated proteins, which 
play a critical role in bone repair and regeneration, namely osteogenesis. These results 
emphasize that these materials can be called an osteoconductive and/or osteoinductive 
material. 
 
Cytokines involved in Mineralization by qRT-PCR analysis 
 In the presence of osteoinductive /osteoconductive materials like MTA, 
Osteoblasts form an extensive matrix and express osteogenic phenotypes. However, 
this favorable response is likely to be modified because of the presence of 
inflammation and inflammatory agents, like bacterial lipopolysaccharides (LPS) that 
are available in vivo. Periradicular inflammation is characterized by the cytokines IL-
1 alpha, IL-6, TNF alpha, etc.30. In particular, IL-1alpha induces most of the bone 
resorbing activity within periapical lesions.60 Despite the presence of inflammatory 
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mediators, materials like MTA have demonstrated remarkable success as root-end 
fillings. Hence it is well understood that the cellular response to those materials like 
MTA may involve in modulating inflammation. Mitchell et al.35 found that osteoblast 
cells produce only IL-6 in response to MTA, without expressing IL-1alpha. Silva et 
al.53 observed that mouse pulp tissues reduce IL-1 alpha expression, and moderate 
levels of TNF alpha expression when treated with MTA after pulpotomy. Hence the 
specific objective was determined in this study whether bacterial LPS–stimulated and 
unstimulated cells differ in their expression of the inflammatory cytokines IL-1 alpha, 
IL-6, and TNF alpha. 
 
           In this study it was found that TNF alpha and IL-6 are detected in moderate to 
high levels in all the experimental groups but significantly less than the control group 
as because experimental materials tend to suppress the inflammatory reaction. IL-
1alpha was more detected in control group and its reduction in the presence of the 
experimental groups was highly significant.  
 
In addition, despite stimulating with Bacterial lipopolysaccharides, it is found 
that IL-1 alpha was minimally detected in the cultures of all experimental materials. 
The IL-6 and TNF alpha was found to be in moderate to high levels in all the 
experimental groups that were treated with bacterial LPS. 
 
Whether the cultures were stimulated with LPS or not, the overall observation 
of the results obtained was that IL-6 expression was maintained, TNF alpha 
expression was detected in low levels and IL-1 alpha expression was highly 
suppressed from 24 to 72 hrs. Osteoblasts produce IL-6 and stimulate osteoclast 
formation thereby bone resorption. But IL-6 has an additional anti inflammatory 
activity because of the suppression of IL-1 alpha. Hence these preosteoblasts 
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maintained IL-6 expressions, whereas their expression of IL-1 alpha appeared to have 
been suppressed with the presence of experimental material. This favors cessation of 
IL-1 alpha induced bone resorption in vivo. The expression of all cytokines between 
the experimental groups was statistically insignificant. This explains that Portland 
Cement can be used in place of MTA after addition of any radiopacifiers like Bismuth 
oxide, Iodoform and Zirconium oxide. 
 
Mineral trioxide aggregate (MTA) has been material of choice in several 
clinical applications. But it is not cost effective and hence its use in all levels of health 
attention is limited. The present study proved that white Portland cement mixed with 
radiopacifying agents (Bismuth oxide/Iodoform/Zirconium dioxide) has similar 
biological responses of MTA.  The in vivo experiment in animals (Rat subcutaneous 
implantation study) was conducted in our department in the year 2010 with the same 
materials and we found that MTA and Portland cement exhibited similar 
inflammatory reaction.  Hence White Portland cement which is cheaper than MTA 
can replace MTA in all clinical situations and it will benefit the people at large.   
 
However, further studies like usage tests (Direct pulp capping, Root end 
filling, Apexification) need to be conducted in vivo in animals and in humans to 
ensure that this material meets the medical device requirement.  
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The aim of the present study was to compare MTA & Portland cement with 
three different Radiopacifying agents (Iodoform, Zirconium oxide, Bismuth oxide) on 
Osteoblast cell survival, alkaline phosphatase activity and genetic expression of 
mineralization.  
 
Materials & Methods  
 
In this study we used clonal mouse pre-osteoblastic cell line (MC3T3-E1) 
because it has high level of differentiation and can express osteoblastic markers. 
Mouse osteoblastic Cell lines MC3T3-E1 were obtained from the National centre for 
cell sciences, Pune. Cells were cultured in Minimal Essential Medium (MEM) 
supplemented with 10% heat inactivated Fetal bovine serum (FBS), 3% L- glutamine, 
100 U/ml penicillin G and 100 µg/ml streptomycin (Hi media) grown at 37°C in a 
humidified atmosphere of 5% CO2 in air. 
 
The Portland cement was added with three different radiopacifiers (Bismuth 
oxide, Iodoform, Zirconium oxide) in the ratio of 4: 1 by weight. Mouse MC3T3-E1 
preosteoblasts (100,000 cells per well) were seeded onto 0.02 mg/ml of samples 
mixed two 24-well tissue culture plates (n=9, 5 groups & 45 wells) for assessing 
cytotoxicity, alkaline phosphatase assay and for detection of mineralization associated 
proteins and cytokines by qRT-PCR analysis and three 24-well tissue culture plates 
(n=9, 6 groups & 54 wells) for detection of LPS stimuated cytokines by qRT-PCR 
analysis. In case of LPS stimulated culture plates, after 6 hours of growth, fresh 
medium was added containing 10 micro g/mL LPS in all the groups except group I 
which serves as a control. 
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Experimental groups were, 
GROUP I  -  Control 
GROUP II  - MTA (Pro Root, Dentsply) 
GROUP III - White Portland Cement 80wt% + Iodoform 20wt% 
GROUP IV - White Portland Cement 80wt% + Zirconium Dioxide 20wt%                           
GROUP V  - White Portland Cement 80wt% + Bismuth Oxide 20wt% 
 
Experimental Groups (LPS stimulated) were, 
GROUP I  -  Control 
GROUP II  - LPS alone  
GROUP III     -           LPS + MTA  
GROUP IV - LPS + White Portland Cement 80wt% + Iodoform 20wt% 
GROUP V - LPS + White Portland Cement 80wt% + Bismuth Oxide 20wt% 
GROUP VI  - LPS + White Portland Cement 80wt% + Bismuth Oxide 20wt%                                     
 
MTT assay 
First, the experimental materials were prepared into 10 different concentrations 
for assessing cell survival ability using MTT assay. The cell survival ability was 
compared among the experimental groups at 10 different concentrations and 0.02 
mg/ml of the experimental samples was chosen as a best concentration and was used 
for further comparisons by alkaline phosphatase assay and qRT-PCR analysis. Then 
the OD values obtained from MTT assay at 0.02 mg/ml of the experimental samples 
were used to compare between the experimental groups at 24, 48 and 72 hrs. 
 
The cytotoxicty results obtained were statistically insignificant between the 
experimental groups. The cell viability with the presence of all experimental groups 
was decreased on the first day and second day but increased significantly on the third 
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day compared to the control group. This was due to the initial high pH of the 
experimental material that inhibited the cell growth on the first and second day. 
 
Alkaline Phosphatase assay 
 Alkaline phosphatase assay was performed at a concentration of 0.02 mg/ml of 
the experimental samples at 3, 7 and 15 days. The alkaline phosphatase results 
obtained were statistically insignificant between the experimental groups. At day 3 
there was reduced cellular differentiation and ALP activity but at day 7 & and day 15, 
ALP activity got increased gradually. 
 
mRNA expression of Mineralizaton by qRT-PCR analysis 
qRT-PCR analysis was performed for detection of mRNA expression of 
mineralization associated proteins (BSP, OPN, OCN, and COL I) at 24, 48 and 72 hrs. 
The results showed that mRNA expression of all mineralization associated proteins 
was minimal at 24 hrs and 48 hrs but recovered to the level of control group at 72 hrs. 
The mRNA expression of all mineralization associated proteins was statistically 
insignificant between the experimental groups. 
 
mRNA expression of Cytokines 
The cytokines involved in the mineralization was observed at 24,48 and 72 hrs 
with and without stimulation with LPS  by qRT-PCR analysis and overall observation 
of the results obtained by qRT-PCR analysis showed that mRNA expression of IL-6 
was maintained, TNF alpha was detected in low levels and IL-1 alpha was highly 
suppressed from 24 to 72 hrs. The expression of all cytokines between the 
experimental groups was statistically insignificant. 
Hence it was concluded that Portland cement can be used in place of MTA after 
addition of any radiopacifiers like Bismuth oxide, Iodoform and Zirconium oxide. 
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From the results of the present study, the following conclusions can be arrived, 
 
ü Portland cement with three different radiopacifying agents (Iodoform, 
Zirconium oxide, Bismuth oxide) at a concentration of 0.02 mg/ml was shown 
to be a nontoxic endodontic material by MTT assay and this cytotoxicity was 
comparable to MTA. 
 
ü The cellular differentiation and alkaline phosphatase activity were increased 
from day 3 to day 15 for both MTA and Portland cement with three different 
radiopacifying agents and the results were statistically insignificant between 
them. 
 
ü Both MTA and Portland cement with three different radiopacifying agents 
expressed mRNA of all mineralization associated proteins (BSP, OPN, OCN, 
and COL I) and these expressions were statistically insignificant between 
them. 
 
ü With and without stimulating with LPS, both MTA and Portland cement with 
three different radiopacifying agents modulated inflammation by expressing 
cytokines TNF α at low levels, IL-1 α at negligible levels and maintaining IL-
6 at moderate levels. These modulations were statistically insignificant 
between them. 
 
ü The result from our study proved that Portland cement can be used in clinical 
situations similar to those in which MTA can be used. Such an inexpensive 
and easily available material provides successful treatments in all patient 
population. Nevertheless, further studies are needed to support the clinical 
applicability of Portland cement.   
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